Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023709	fs-gh	ug/l (ug/l)	1442	3783	1.74%
3023709	s-gh	ug/l (ug/l)	117	214	0.00%
3023709	s-gh	— (—)	60	84	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Endocrine, nutritional and metabolic diseases

513

244

10.73

315.34

3.0

1.4

1.27

1.03

ug/l

0.99

474

236

Benign neoplasm of other and unspecified endocrine glands

474

111

46.56

307.65

3.7

1.5

1.03

1.10

ug/l

0.13

458

103

Exclusions for E4_PCOS_BROAD

889

140

71.31

307.65

3.3

2.4

1.12

1.61

ug/l

2.02

834

133

Disorders of other endocrine glands

926

315

30.06

307.65

3.4

1.4

1.21

1.35

ug/l

0.47

865

301

Exclusions for E4_PCOS_CONSORTIUM

845

413

13.05

307.65

3.2

1.7

1.12

1.43

ug/l

1.60

789

397

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

809

245

34.65

307.65

3.4

1.7

1.05

1.36

ug/l

1.41

761

233

Used for control exclusion in common control thyroid runs

656

394

8.48

307.65

2.9

1.9

1.15

1.35

ug/l

0.84

607

381

Short stature, not elsewhere classified

144

75.37

248.94

6.4

2.9

1.99

3.90

ug/l

1.35

144

Panhypopituitarism

127

111.74

247.16

2.7

2.1

0.79

1.04

ug/l

0.23

119

Hypothyroidism, other/unspecified

486

667

4.82

184.62

2.4

2.3

1.05

1.17

ug/l

0.46

454

636

Disorders of the thyroid gland

501

708

4.64

181.39

2.3

2.2

1.07

1.13

ug/l

0.18

468

675

Other disorders of adrenal gland

106

46.86

180.10

2.0

1.3

1.53

1.63

ug/l

0.07

Hypothyreosis and Thyroxine purchase for inclusion criteria

497

724

4.53

175.83

2.4

2.3

1.05

1.18

ug/l

0.52

465

692

Adrenocortical insufficiency

58.52

165.28

1.8

1.2

1.68

1.24

ug/l

0.39

Thyrotropin deficiency

79.27

133.41

2.3

2.5

0.87

1.47

ug/l

0.53

Benign neoplasms

464

682

3.77

122.25

2.9

1.9

1.10

1.15

ug/l

0.19

432

631

Neoplasms

380

597

3.39

85.41

2.8

2.4

1.09

1.27

ug/l

0.79

355

554

Sleep apnoea

368

780

3.07

76.19

2.3

0.99

1.13

ug/l

0.48

332

746

Sleep apnoea, including avohilmo

378

821

2.86

68.73

2.2

2.3

1.07

1.13

ug/l

0.19

341

786

Medical observation and evaluation for suspected diseases and conditions

288

429

3.45

65.63

1.9

2.6

0.94

1.20

ug/l

1.13

267

401

Sleep disorders (combined)

410

814

2.65

61.66

2.1

2.5

1.12

1.16

ug/l

0.15

381

778

Headache

275

724

3.05

60.08

2.5

2.8

1.13

1.04

ug/l

0.23

262

688

General symptoms and signs

409

799

2.57

57.24

2.0

2.8

1.19

1.01

ug/l

0.86

377

752

Hypothyroidism, strict autoimmune

184

302

4.02

56.92

1.3

1.5

1.15

1.10

ug/l

0.13

168

294

Episodal and paroxysmal disorders

415

847

2.50

55.26

2.4

2.8

1.12

1.31

ug/l

0.89

380

815

First line medication for Crohn's disease

423

975

2.35

50.55

2.4

2.7

1.03

1.20

ug/l

0.88

392

921

Malaise and fatigue

191

463

3.33

48.57

1.7

3.1

1.35

1.03

ug/l

1.06

180

444

Other disorders of fluid, electrolyte and acid-base balance

124

275

4.32

47.72

2.3

2.4

1.06

1.07

ug/l

0.02

119

261

Neurological diseases

323

653

2.49

42.73

2.3

3.1

1.13

1.35

ug/l

0.93

295

627

Short stature starting before birth

17.95

42.42

6.4

2.26

2.62

ug/l

0.20

Mood disorders, excluding more controls

330

832

2.37

41.60

1.8

2.4

0.90

1.09

ug/l

0.95

305

786

Abnormalities of breathing

346

868

2.32

41.24

2.1

2.9

1.21

1.18

ug/l

0.10

322

821

Mood [affective] disorders

357

1051

2.21

39.01

1.9

2.4

0.91

1.11

ug/l

1.12

329

991

Mood disorders

357

1051

2.20

38.84

1.9

2.4

0.91

1.11

ug/l

1.12

329

991

Depression

340

1035

2.23

38.59

1.9

2.5

0.99

1.12

ug/l

0.56

315

975

Recurrent or chronic depression

154

335

3.25

36.22

1.6

2.4

0.75

1.09

ug/l

1.28

143

316

Other antidepressants

322

721

2.29

36.08

1.7

2.4

0.86

1.09

ug/l

1.21

292

680

Hypertension, essential

265

610

2.47

35.74

2.2

2.0

1.15

0.92

ug/l

0.91

247

566

Depression or dysthymia

221

457

2.68

34.73

2.1

2.6

0.77

1.10

ug/l

1.59

208

437

Hypertensive diseases (excluding secondary)

220

485

2.65

34.35

2.5

2.8

1.22

1.09

ug/l

0.36

205

454

Metabolic disorders

319

888

2.20

34.06

3.0

2.4

1.08

1.20

ug/l

0.50

298

833

Benign neoplasm of meninges

100

5.97

33.36

2.5

2.1

0.71

1.27

ug/l

1.66

Benign neoplasm: Cerebral meninges

6.23

33.03

2.5

1.9

0.74

1.33

ug/l

1.60

Visual disturbances and blindness

189

729

2.60

32.83

2.4

2.7

1.10

1.25

ug/l

0.51

183

686

Any reimbursement code in KELA

227

443

2.58

32.19

2.7

2.3

1.30

1.15

ug/l

0.37

210

416

Anxiety disorders, excluding more controls

282

826

2.23

31.66

2.1

2.5

1.06

1.14

ug/l

0.25

267

780

Visual disturbances

178

685

2.61

31.13

2.2

2.6

1.11

1.19

ug/l

0.23

172

647

Hypertension

273

685

2.26

30.42

2.3

2.4

1.26

1.05

ug/l

0.76

254

638

Hypertensive diseases

273

686

2.25

30.33

2.3

2.5

1.26

1.05

ug/l

0.76

254

639

Selective serotonin reuptake inhibitors

308

756

2.13

29.38

1.8

2.6

1.05

1.10

ug/l

0.17

285

715

Any gastric operation

289

661

2.20

29.34

2.6

1.39

1.09

ug/l

1.41

266

624

GASTRO-related operations

289

661

2.20

29.34

2.6

1.39

1.09

ug/l

1.41

266

624

Fever of other and unknown origin

180

634

2.53

29.01

2.2

2.9

1.21

1.04

ug/l

0.54

167

605

Oedema, not elsewhere classified

285

3.41

27.48

1.7

2.7

1.04

1.09

ug/l

0.07

275

Neurological diseases, wide definition

152

260

2.95

27.48

2.5

3.6

1.11

1.47

ug/l

1.15

136

253

Codeine

301

795

2.06

26.75

2.1

0.99

1.04

ug/l

0.17

283

744

Benzodiazepine use

317

1106

1.98

26.67

1.9

2.4

1.06

1.10

ug/l

0.11

297

1036

Codeine or tramadol medication

342

960

1.95

26.31

2.1

2.2

0.99

1.08

ug/l

0.32

321

895

Neurotic, stress-related and somatoform disorders

304

1081

1.97

25.50

2.1

2.5

1.08

1.12

ug/l

0.10

289

1011

Anxiety disorders

305

1087

1.96

25.12

2.1

2.5

1.08

1.12

ug/l

0.12

290

1017

Other special examinations and investigations of persons without complaint or reported diagnosis

202

429

2.39

24.88

2.4

2.6

1.22

1.20

ug/l

0.04

184

401

Other headache syndromes

133

496

2.69

24.82

2.2

2.4

0.96

1.26

ug/l

0.91

126

479

Intracranial trauma

184

549

2.36

24.27

2.2

3.1

1.07

1.35

ug/l

0.92

174

527

General examination and investigation of persons without complaint and reported diagnosis

194

429

2.37

23.64

2.1

2.6

1.33

1.20

ug/l

0.21

182

401

Persons encountering health services in other circumstances

151

612

2.46

23.57

2.0

2.8

0.96

1.17

ug/l

0.66

139

583

Obesity related asthma

125

470

2.67

23.07

2.1

2.5

0.97

1.07

ug/l

0.22

113

445

Persons with potential health hazards related to communicable diseases

175

762

2.29

23.06

2.6

2.9

1.29

1.32

ug/l

0.07

169

717

Antihypertensive medication - note that there are other indications

246

624

2.10

22.73

2.2

3.0

1.51

1.16

ug/l

1.34

229

583

Symptoms and signs involving the circulatory and respiratory systems

328

871

1.89

22.54

2.0

2.9

1.33

1.18

ug/l

0.53

309

823

Brain meningioma

6.84

22.54

2.3

1.6

0.80

1.24

ug/l

0.76

Anxiety (asthma-related co-morbidities)

218

805

2.10

22.25

2.1

2.6

1.13

1.11

ug/l

0.05

209

755

Mouth breathing

152

644

2.37

21.77

2.5

3.0

1.16

1.30

ug/l

0.29

138

611

Brain meningioma, including Hilmo

6.58

21.77

2.3

1.6

0.80

1.20

ug/l

0.67

Other nutritional deficiencies

220

1016

2.04

21.72

1.9

2.5

0.77

1.21

ug/l

3.46

201

970

Behavioural syndromes associated with physiological disturbances and physical factors

294

1110

1.88

21.68

2.1

2.5

1.13

1.16

ug/l

0.08

277

1039

Implicit viral Sepsis

338

2.91

21.30

2.3

2.8

1.38

1.15

ug/l

0.45

318

Opioids

295

815

1.88

20.33

2.2

1.03

1.05

ug/l

0.05

273

764

Concussion

153

538

2.33

20.30

2.4

3.1

0.95

1.35

ug/l

1.86

144

516

All anxiety disorders

222

876

2.01

20.23

2.1

2.4

1.12

1.08

ug/l

0.08

212

812

Exposure to unspecified factor

316

1268

1.80

20.23

2.2

2.7

1.19

1.20

ug/l

0.04

296

1198

Persons encountering health services in other circumstances, wide

362

1059

1.76

20.19

2.3

2.7

1.23

1.15

ug/l

0.27

331

1005

Diarrhoea and gastroenteritis of presumed infectious origin

315

1153

1.80

20.09

2.4

2.6

1.20

1.17

ug/l

0.10

297

1085

Contact with and exposure to communicable diseases

146

631

2.31

19.89

2.4

2.9

1.32

1.34

ug/l

0.03

141

594

Obesity and other hyperalimentation

205

978

2.02

19.85

1.9

2.5

0.66

1.21

ug/l

6.29

187

931

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

177

740

2.15

19.72

2.1

2.5

1.00

1.12

ug/l

0.42

169

703

Obesity

204

977

2.02

19.64

1.9

2.5

0.66

1.21

ug/l

6.25

186

930

Any mental disorder

322

891

1.81

19.55

2.3

2.6

1.20

1.17

ug/l

0.07

303

845

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

168

757

2.16

19.39

2.2

2.4

1.33

1.10

ug/l

0.33

162

709

Psychiatric diseases

290

791

1.84

18.47

2.5

2.6

1.20

1.18

ug/l

0.05

273

751

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

121

231

2.63

18.19

2.3

3.0

1.28

0.88

ug/l

1.16

108

211

Sleep disorders

267

1058

1.83

18.14

2.0

2.3

1.02

1.14

ug/l

0.45

252

987

Other disorders of lacrimal gland

108

428

2.53

18.03

2.2

2.4

1.29

1.11

ug/l

0.37

102

402

Nausea and vomiting

102

386

2.60

17.88

2.5

3.4

1.85

1.37

ug/l

0.92

369

Implicit Sepsis

235

911

1.89

17.77

2.1

2.6

1.33

1.09

ug/l

0.86

220

857

Polycystic ovarian syndrome, consortium definition

205

607

2.01

17.55

2.2

1.27

1.24

ug/l

0.06

195

586

Cardiovascular diseases

241

681

1.91

17.46

2.5

3.0

1.49

1.24

ug/l

0.81

221

645

Parasetamol

233

610

1.94

17.45

2.1

2.3

1.07

0.95

ug/l

0.36

212

569

Gastro-oesophageal reflux disease

198

870

1.97

17.44

2.2

2.5

1.22

1.06

ug/l

0.45

182

828

Intestinal infectious diseases

290

1257

1.75

17.38

2.5

2.6

1.26

1.19

ug/l

0.22

276

1181

Other soft tissue disorders, not elsewhere classified

294

973

1.77

17.38

2.1

2.8

1.16

1.18

ug/l

0.07

273

920

Other anxiety disorders

166

690

2.09

17.27

2.1

2.4

1.16

1.13

ug/l

0.07

159

637

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

294

1162

1.75

17.12

2.3

2.7

1.07

1.23

ug/l

0.73

275

1103

Asthma, excluding more controls

229

620

1.93

17.07

2.3

2.8

1.25

1.08

ug/l

0.46

213

590

Cardiovascular diseases (excluding rheumatic etc)

244

751

1.87

17.06

2.5

2.9

1.38

1.21

ug/l

0.48

225

708

Asthma

232

636

1.92

16.97

2.3

2.8

1.25

1.09

ug/l

0.44

216

606

Other diseases of intestines

331

1112

1.70

16.63

2.8

2.5

1.31

1.18

ug/l

0.45

305

1050

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

375

2.56

16.41

1.2

2.3

1.07

1.16

ug/l

0.23

351

Implicit Sepsis

209

830

1.90

16.31

2.1

2.6

1.41

1.06

ug/l

1.30

197

782

Low back pain

220

845

1.87

16.20

2.1

2.4

1.10

1.11

ug/l

0.02

206

793

Intestinal infectious diseases

336

1150

1.67

16.06

2.4

2.6

1.28

1.16

ug/l

0.44

320

1082

Gastrointestinal diseases

207

530

1.96

16.00

2.9

2.6

1.42

1.13

ug/l

0.88

190

504

Aplastic and other anaemias

114

454

2.35

15.98

2.2

2.7

1.12

1.14

ug/l

0.02

108

435

Other anaemias

105

412

2.43

15.95

2.2

2.6

1.09

1.16

ug/l

0.13

394

Diarrhoea and gastroenteritis of presumed infectious origin

224

1113

1.82

15.64

2.5

2.6

1.20

1.22

ug/l

0.06

213

1039

Pain in joint

176

558

2.02

15.63

2.1

2.7

1.02

1.11

ug/l

0.26

159

522

Implicit bacterial Sepsis

112

412

2.35

15.58

1.8

2.6

1.50

0.93

ug/l

1.60

107

390

Asthma, unspecified (mode), excluding more controls

155

558

2.08

15.57

2.1

2.8

0.90

1.09

ug/l

0.80

149

537

Asthma (mode)

224

640

1.88

15.57

2.3

2.8

1.23

1.09

ug/l

0.38

209

610

Other and unspecified anaemias

103

407

2.42

15.52

2.2

2.6

1.11

1.16

ug/l

0.08

389

Irregular menses

148

556

2.11

15.50

2.2

1.13

1.22

ug/l

0.21

140

538

Obesity due to excess calories

150

730

2.06

15.48

1.8

2.6

0.65

1.26

ug/l

5.34

137

696

Condition for Implicit Sepsis (Organ dysfunction codes)

241

950

1.79

15.45

2.1

2.6

1.33

1.08

ug/l

0.95

226

895

Syncope and collapse

111

405

2.35

15.40

1.7

2.7

1.06

0.95

ug/l

0.30

104

386

Nerve, nerve root and plexus disorders

285

1017

1.72

15.35

2.2

0.96

1.13

ug/l

0.75

266

953

Asthma, unspecified (mode)

156

572

2.06

15.23

2.1

2.8

0.90

1.11

ug/l

0.85

150

551

Asthma (only as main-diagnosis), excluding more controls

206

620

1.90

15.17

2.2

2.8

1.26

1.08

ug/l

0.45

190

590

Disorders of lacrimal system

119

532

2.24

15.15

2.2

2.4

1.24

1.14

ug/l

0.21

113

502

Nontoxic goitre/thyroid nodule

305

2.67

15.08

2.5

2.1

1.17

1.10

ug/l

0.12

288

Hypothyroidism, strict autoimmune, 3 medication purchases required

189

666

1.92

14.86

1.3

2.2

1.15

1.14

ug/l

0.04

173

639

Tramadol

213

706

1.86

14.83

1.8

2.2

0.99

1.04

ug/l

0.14

205

663

Pain in limb

243

920

1.77

14.78

2.0

2.8

1.13

1.19

ug/l

0.18

227

876

Abnormalities of heart beat

401

2.40

14.67

1.6

2.6

1.64

1.06

ug/l

0.75

379

Asthma (only as main-diagnosis)

206

636

1.88

14.65

2.2

2.8

1.26

1.09

ug/l

0.43

190

606

Condition for Implicit Sepsis (Organ dysfunction codes)

258

1031

1.73

14.54

2.1

2.5

1.30

1.12

ug/l

0.59

243

971

Personality disorders, excluding more controls

346

2.52

14.51

1.4

2.3

1.06

1.11

ug/l

0.09

317

Diseases of the ear and mastoid process

339

1043

1.63

14.49

2.1

2.6

1.07

1.16

ug/l

0.31

315

981

Insomnia

250

1051

1.74

14.47

2.0

2.3

1.02

1.10

ug/l

0.26

237

978

Spondylosis

133

511

2.13

14.39

1.7

2.3

1.01

1.08

ug/l

0.11

124

486

Symptoms and signs involving cognition, perception, emotional state and behaviour

269

1078

1.70

14.39

2.2

2.4

1.27

1.09

ug/l

0.73

253

1019

Bipolar affective disorders

262

2.76

14.35

1.3

2.4

1.03

1.19

ug/l

0.26

241

Persons encountering health services for other counselling and medical advice, not elsewhere classified

320

1058

1.65

14.35

2.4

2.7

1.32

1.15

ug/l

0.49

296

1004

Pain in throat and chest

239

811

1.77

14.29

1.9

2.8

1.18

1.09

ug/l

0.25

224

765

Symptoms and signs involving the nervous and musculoskeletal systems

168

878

1.92

14.18

2.0

2.8

1.50

1.24

ug/l

0.61

158

835

Oral corticosteroids

301

1079

1.66

14.14

1.8

2.5

1.11

1.10

ug/l

0.02

286

1009

Diseases of the eye and adnexa

268

778

1.73

14.09

2.5

2.7

1.34

1.16

ug/l

0.59

254

720

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

352

2.48

14.02

2.0

2.2

1.05

1.01

ug/l

0.07

331

Glucagon-like peptide-1 (GLP-1) analogues

352

2.48

14.02

2.0

2.2

1.05

1.01

ug/l

0.07

331

Dyspnoea

243

1039

1.73

13.99

1.9

2.6

1.08

1.18

ug/l

0.40

224

993

ILD medications: prednisolone, methylprednisolone, prednisone

318

1090

1.63

13.97

2.0

2.7

1.15

1.17

ug/l

0.04

296

1030

Bacterial Sepsis

115

446

2.21

13.83

2.1

2.6

1.49

0.97

ug/l

1.43

110

423

Pain (limb, back, neck, head abdominally)

221

609

1.82

13.82

2.4

2.9

1.36

1.20

ug/l

0.38

208

573

Diseases of oesophagus, stomach and duodenum

299

1090

1.64

13.62

2.3

2.5

1.43

1.04

ug/l

1.50

278

1028

Disorders of lipoprotein metabolism and other lipidaemias

193

646

1.85

13.44

2.5

2.1

0.97

1.01

ug/l

0.14

181

603

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

110

446

2.21

13.27

3.0

3.1

1.61

1.38

ug/l

0.44

105

418

Type 2 diabetes, wide definition

192

668

1.84

13.25

2.3

2.2

1.17

0.98

ug/l

0.41

176

629

Complications of procedures, not elsewhere classified

218

1035

1.75

13.24

2.4

2.3

1.17

1.14

ug/l

0.06

209

977

Other functional intestinal disorders

133

609

2.03

13.13

2.7

2.9

1.24

1.37

ug/l

0.28

124

585

Other symptoms and signs involving the nervous and musculoskeletal systems

128

628

2.04

13.01

2.0

2.8

1.42

1.14

ug/l

0.64

123

596

Poisoning by medicine

341

2.45

12.99

1.3

2.4

1.07

1.02

ug/l

0.09

313

Obesity, other/unspecified

108

497

2.18

12.98

1.9

2.3

0.67

1.26

ug/l

3.76

472

Poisoning by drugs, medicaments and biological substances

376

2.35

12.64

1.3

2.4

1.09

1.05

ug/l

0.08

346

ILD medications

330

1136

1.58

12.53

2.1

2.8

1.11

1.19

ug/l

0.27

305

1076

Triptan medication for migraine, min. 3 purchases

176

733

1.84

12.48

1.9

2.4

0.95

1.24

ug/l

1.36

169

694

Spondylopathies

196

651

1.80

12.43

1.8

2.4

0.98

1.07

ug/l

0.19

180

618

Other symptoms and signs involving cognitive functions and awareness

105

441

2.17

12.34

2.2

2.4

1.06

1.03

ug/l

0.07

417

147

767

1.91

12.26

2.7

2.9

1.23

1.28

ug/l

0.08

137

728

Dorsalgia

272

889

1.64

12.12

1.8

2.4

0.98

1.11

ug/l

0.56

253

835

Dizziness and giddiness

185

822

1.79

12.12

2.2

2.4

1.27

1.08

ug/l

0.64

174

782

Symptoms and signs involving the skin and subcutaneous tissue

192

1076

1.75

12.11

2.5

1.42

1.15

ug/l

0.67

182

1024

Nonorganic sleeping disorders, excluding more controls

263

2.60

12.10

2.2

2.6

0.88

1.17

ug/l

0.64

244

Symptoms and signs involving the urinary system

194

842

1.76

11.95

2.3

2.5

1.30

1.11

ug/l

0.37

185

794

Nontoxic multinodular goitre

125

3.37

11.87

2.5

1.7

1.32

1.10

ug/l

0.25

119

Asthma-related infections

171

934

1.80

11.82

2.5

2.7

1.23

1.26

ug/l

0.05

160

883

Asthma, hospital admission 2, infections

171

934

1.80

11.82

2.5

2.7

1.23

1.26

ug/l

0.05

160

883

Other dorsopathies, not elsewhere classified

277

897

1.62

11.64

2.0

2.5

1.01

1.11

ug/l

0.35

257

843

Acetic acid derivatives and related substances

142

2.68

11.61

1.7

2.1

1.33

0.86

ug/l

0.92

135

Symptoms and signs involving the digestive system and abdomen

287

899

1.60

11.47

2.3

2.8

1.30

1.13

ug/l

0.50

269

846

Type 2 diabetes, definitions combined

244

869

1.65

11.39

2.2

0.94

1.04

ug/l

0.34

224

820

Persons encountering health services for examination and investigation

161

429

1.88

11.30

2.3

2.6

1.02

1.20

ug/l

0.45

149

401

Examination and observation for other reasons

143

429

1.93

11.20

2.9

2.6

1.36

1.20

ug/l

0.36

134

401

Type 2 diabetes, strict (exclude DM1)

244

875

1.64

11.11

2.2

0.94

1.03

ug/l

0.33

224

826

Diseases of the musculoskeletal system and connective tissue

194

552

1.77

11.11

2.6

3.0

1.27

ug/l

0.00

177

525

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

278

1148

1.58

11.09

2.6

2.7

1.56

1.12

ug/l

2.45

266

1088

Migraine, single triptan purchase ok & required. ICD-code if available is included

226

925

1.66

11.05

2.1

2.4

1.04

1.14

ug/l

0.34

206

870

Triptan medication for migraine, single purchase ok

226

925

1.66

11.05

2.1

2.4

1.04

1.14

ug/l

0.34

206

870

Continuous positive airway pressure

223

2.54

11.04

2.7

3.9

1.50

1.45

ug/l

0.06

217

Diaphragmatic hernia

387

2.23

11.00

2.0

2.2

0.77

0.98

ug/l

1.05

364

Disorders of calcium metabolism

4.52

10.95

3.3

2.3

1.06

1.64

ug/l

0.63

Pure hypercholesterolaemia

158

563

1.83

10.91

2.5

2.1

0.93

1.04

ug/l

0.37

151

524

Diseases of inner ear

124

620

1.94

10.89

1.7

2.3

1.04

1.07

ug/l

0.05

115

590

Autoimmune diseases related-to ILD

230

1212

1.63

10.87

2.1

2.4

1.22

1.07

ug/l

0.49

209

1144

Soft tissue disorders

301

995

1.56

10.86

2.5

2.8

1.15

1.18

ug/l

0.10

280

942

Primary adrenocortical insufficiency

18.43

10.80

1.2

2.2

0.91

1.44

ug/l

—

Dysphagia

244

2.55

10.70

2.3

2.6

1.07

1.05

ug/l

0.02

230

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

114

571

1.98

10.68

3.4

3.0

1.73

1.39

ug/l

0.77

106

545

Injuries to the head

312

1257

1.53

10.68

2.3

2.6

1.23

1.18

ug/l

0.17

297

1183

Complications of surgical and medical care, not elsewhere classified

257

1109

1.59

10.66

2.4

2.3

1.15

1.12

ug/l

0.09

245

1042

Abdominal and pelvic pain

282

899

1.58

10.64

2.1

2.8

1.22

1.13

ug/l

0.21

263

846

Genitourinary diseases

201

586

1.72

10.61

2.7

3.1

1.21

1.17

ug/l

0.09

186

548

Dorsopathies

288

935

1.57

10.61

2.1

2.6

1.01

1.16

ug/l

0.64

269

881

Type 2 diabetes, definitions combined, including avohilmo

243

876

1.62

10.50

2.2

0.90

1.02

ug/l

0.55

221

829

Benign neoplasm of colon, rectum, anus and anal canal

133

617

1.87

10.41

4.5

1.8

1.33

1.02

ug/l

0.49

128

581

Autoimmune diseases excluding thyroid diseases

294

1039

1.55

10.37

2.4

2.9

1.36

1.08

ug/l

1.09

275

987

Dentofacial anomalies [including malocclusion]

213

1045

1.64

10.34

2.9

2.5

1.15

1.20

ug/l

0.15

205

981

Disorders of vestibular function (Vertigo)

108

535

1.99

10.29

1.7

2.3

1.09

1.00

ug/l

0.16

100

509

Asthma (diagnoses ohter than nonallergic)

241

1262

1.59

10.28

2.3

2.6

1.13

1.24

ug/l

0.31

226

1198

Lower back pain or/and sciatica

272

1146

1.55

10.14

2.0

2.3

1.03

1.08

ug/l

0.19

257

1073

Autoimmune diseases

314

1052

1.52

10.12

2.0

2.9

1.32

1.11

ug/l

0.77

283

1000

Asthma, hospital admissions , main diagnosis only

228

1261

1.60

10.12

2.4

2.6

1.23

1.22

ug/l

0.04

212

1197

ILD differential diagnosis

213

640

1.67

10.07

1.9

2.8

1.22

1.09

ug/l

0.38

196

610

Acute upper respiratory infections of multiple and unspecified sites

214

974

1.63

10.05

2.1

2.7

1.31

1.13

ug/l

0.48

197

930

COPD differential diagnosis

213

641

1.67

10.02

1.9

2.8

1.22

1.09

ug/l

0.38

196

611

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

149

830

1.77

10.00

2.6

2.3

1.20

1.19

ug/l

0.02

142

787

Cerebrovascular diseases (FINNGEN)

228

2.33

9.96

2.6

2.2

1.17

0.92

ug/l

0.46

217

Type 2 diabetes

250

925

1.58

9.89

2.3

2.2

1.07

1.05

ug/l

0.05

227

871

Excluding asthma or asthma-COPD overlap

213

644

1.66

9.86

1.9

2.8

1.29

1.08

ug/l

0.65

198

612

Other diseases of upper respiratory tract

291

990

1.53

9.84

2.4

2.7

1.28

1.21

ug/l

0.15

274

934

Inflammatory bowel disease treatment related agents

314

1172

1.50

9.75

2.1

2.6

1.22

1.13

ug/l

0.30

296

1102

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

475

2.03

9.68

1.2

2.3

1.07

1.15

ug/l

0.19

444

Other pulmonary diagnosis

212

644

1.65

9.65

1.9

2.8

1.29

1.08

ug/l

0.65

197

612

Coxibs

150

2.46

9.63

1.7

2.2

0.80

0.88

ug/l

0.15

143

Disorders of eyelid, lacrimal system and orbit

210

990

1.61

9.51

2.2

2.5

1.24

1.18

ug/l

0.15

202

942

Pain, not elsewhere classified

308

2.28

9.51

2.2

3.0

0.96

1.15

ug/l

0.53

293

Pain and other conditions associated with female genital organs and menstrual cycle

248

2.38

9.43

2.1

1.36

1.19

ug/l

0.22

239

Diverticular disease of intestine

145

517

1.79

9.34

3.5

1.8

1.12

0.97

ug/l

0.42

135

491

Falls/tendency to fall

314

1056

1.49

9.26

2.3

2.7

1.38

1.17

ug/l

0.90

288

1001

Spinal stenosis

103

397

1.97

9.20

1.8

2.3

1.30

1.01

ug/l

0.43

380

Disturbances of skin sensation

404

2.09

9.17

2.8

2.3

1.24

1.01

ug/l

0.52

379

Other neurological diseases

161

742

1.71

9.15

2.4

2.3

1.20

1.10

ug/l

0.21

150

706

Complications of medical and surgical care

178

993

1.65

9.13

2.4

2.3

1.09

1.18

ug/l

0.22

169

942

Chronic rhinitis, nasopharyngitis and pharyngitis

466

2.00

9.08

2.1

2.7

0.92

1.22

ug/l

0.89

442

Other bacterial diseases

273

1147

1.51

9.06

2.2

2.6

1.24

1.16

ug/l

0.20

258

1078

Intracranial injury

158

882

1.70

9.05

2.2

2.8

1.03

1.16

ug/l

0.36

150

823

Influenza and pneumonia

295

1263

1.49

9.03

2.3

2.6

1.18

1.20

ug/l

0.07

276

1193

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

116

385

1.91

9.02

2.0

2.3

1.80

1.01

ug/l

1.29

105

364

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

134

760

1.76

8.89

2.6

2.3

1.24

1.22

ug/l

0.02

127

720

Other and unspecified iron deficiency

423

2.04

8.84

2.5

2.7

1.46

1.22

ug/l

0.57

403

Specific personality disorders

377

2.10

8.83

1.3

2.3

1.06

1.07

ug/l

0.02

348

Iron deficiency anaemia

101

522

1.91

8.64

2.4

2.7

1.38

1.20

ug/l

0.42

499

Chronic apical periodontitis

283

1082

1.49

8.63

2.3

2.2

0.87

1.15

ug/l

2.06

261

1019

Factors influencing health status and contact with health services

186

2.19

8.56

2.6

2.7

1.59

1.23

ug/l

0.48

173

Use of hypnotics and sedatives

272

1043

1.50

8.53

1.8

2.5

1.03

1.12

ug/l

0.31

255

977

Other specific joint derangements/joint disorders

208

854

1.58

8.38

2.0

2.4

1.03

1.08

ug/l

0.15

190

807

Nutritional anaemias

112

591

1.83

8.37

2.3

2.6

1.29

1.21

ug/l

0.16

563

Constipation

222

995

1.55

8.34

2.2

2.8

1.25

1.26

ug/l

0.00

204

959

Personality disorders

440

1.98

8.33

1.4

2.3

1.06

1.07

ug/l

0.02

408

Presence of other functional implants

120

458

1.82

8.32

1.8

2.4

1.22

0.97

ug/l

0.54

113

439

Fall on same level

320

1210

1.45

8.30

2.3

2.7

1.30

1.17

ug/l

0.39

299

1144

Dermatitis and eczema

293

1244

1.46

8.25

2.1

2.6

1.18

ug/l

0.00

271

1177

Symptoms and signs involving speech and voice

401

2.03

8.23

1.9

2.3

1.62

0.99

ug/l

1.17

380

Acute upper respiratory infections

261

1079

1.49

8.14

2.1

2.6

1.22

1.14

ug/l

0.22

238

1035

Voice disturbances

330

2.13

8.11

2.0

2.3

1.29

1.04

ug/l

0.34

313

Other/unspecified dorsalgia

468

1.93

8.09

1.3

2.5

0.93

1.20

ug/l

0.75

443

Systemic connective tissue disorders

418

1.99

8.05

1.8

2.5

1.39

1.13

ug/l

0.56

397

Diseases of the respiratory system

172

521

1.66

8.02

2.2

2.9

1.24

1.13

ug/l

0.26

157

502

Certain infectious and parasitic diseases

272

918

1.49

7.97

2.3

2.7

1.30

1.19

ug/l

0.31

251

870

Other and unspecified effects of external causes

484

1.91

7.88

2.0

2.8

1.03

1.32

ug/l

0.74

455

Lack of expected normal physiological development

3.11

7.87

4.8

6.0

2.64

1.69

ug/l

1.40

Arthrosis

171

573

1.64

7.85

2.7

2.0

1.12

0.94

ug/l

0.53

155

543

Unspecified mental disorder

114

643

1.78

7.81

1.2

2.3

1.14

0.98

ug/l

0.33

105

588

Diabetes, varying definitions

273

1092

1.47

7.80

2.4

2.5

1.09

1.11

ug/l

0.05

249

1031

Haemorrhage from respiratory passages

318

2.07

7.79

2.0

3.0

0.87

1.15

ug/l

0.92

303

Diabetes mellitus

274

1094

1.47

7.78

2.4

2.5

1.09

1.11

ug/l

0.07

250

1033

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

228

910

1.52

7.74

1.9

2.7

1.13

1.17

ug/l

0.11

215

873

228

910

1.52

7.74

1.9

2.7

1.13

1.17

ug/l

0.11

215

873

Myalgia

286

2.17

7.61

2.1

2.7

1.23

1.09

ug/l

0.20

274

Other and unspecified mood [affective] disorders

3.11

7.55

1.8

2.7

1.09

1.20

ug/l

0.15

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

255

2.24

7.55

1.2

2.3

1.05

0.99

ug/l

0.11

232

Vasomotor and allergic rhinitis

119

676

1.73

7.46

2.3

3.0

0.94

1.36

ug/l

1.27

108

637

Carpal tunnel syndrome

134

703

1.68

7.45

2.6

2.2

1.05

1.16

ug/l

0.28

127

670

All kidney diseases

257

1203

1.46

7.43

2.3

2.6

1.45

1.14

ug/l

0.99

246

1136

Urticaria and erythema

111

633

1.76

7.36

2.4

2.8

1.17

1.36

ug/l

0.55

103

601

Diseases of male genital organs

155

473

1.66

7.29

2.6

3.0

1.07

1.09

ug/l

0.03

138

438

Deforming dorsopathies

359

2.01

7.23

2.5

2.9

0.81

1.20

ug/l

1.59

340

Other arrhythmias

157

736

1.61

7.21

1.7

2.5

1.45

1.07

ug/l

0.67

147

697

Dermatitis

150

930

1.61

7.16

1.8

2.7

1.28

1.21

ug/l

0.15

137

889

All pneumoniae

272

1269

1.43

7.11

2.2

2.7

1.22

1.20

ug/l

0.05

255

1197

Cough

103

549

1.78

7.07

2.0

3.2

1.15

1.29

ug/l

0.35

525

Other bacterial diseases

237

1085

1.47

7.06

2.2

2.6

1.32

1.14

ug/l

0.54

224

1015

Acute tubulo-interstitial nephritis

147

788

1.61

6.93

2.2

2.6

1.26

1.19

ug/l

0.15

138

754

Disorders of adult personality and behaviour

477

1.85

6.93

1.4

2.3

1.05

1.12

ug/l

0.15

444

Sensorineural hearing loss

156

661

1.60

6.92

2.0

2.4

1.00

1.08

ug/l

0.24

148

627

Suicide or other Intentional self-harm

372

1.97

6.92

1.2

2.2

1.11

1.06

ug/l

0.08

343

Heart failure, not strict

160

683

1.59

6.90

1.9

2.7

1.44

1.04

ug/l

1.43

154

648

Persons encountering health services for specific procedures and health care

291

1236

1.41

6.90

2.5

2.6

1.30

1.16

ug/l

0.37

279

1161

Other (not insulin) diabetes medications

230

925

1.48

6.87

2.3

2.2

1.13

1.03

ug/l

0.22

207

875

Nonorganic sleeping disorders

339

2.01

6.86

2.2

2.4

0.88

1.22

ug/l

0.78

314

Autoimmune diseases excluding thyroid diseases, strict definition

217

794

1.50

6.84

2.2

2.8

1.40

1.15

ug/l

0.80

201

753

Excessive, frequent and irregular menstruation

280

1.86

6.80

1.9

2.2

1.08

1.21

ug/l

0.23

270

Diseases of the skin and subcutaneous tissue

265

923

1.44

6.77

2.0

2.7

1.31

1.20

ug/l

0.30

243

873

Benign neoplasm: Ascending colon

126

2.71

6.75

6.6

1.8

1.21

1.11

ug/l

0.12

117

Renal tubulo-interstitial diseases

210

1057

1.48

6.65

2.1

2.6

1.47

1.19

ug/l

0.92

199

1009

Osteopathies and chondropathies

129

733

1.64

6.64

2.3

2.5

1.34

1.12

ug/l

0.57

120

695

Mental and behavioural disorders due to opioids

3.59

6.60

1.0

2.5

1.10

1.07

ug/l

0.01

COPD/asthma/ILD related infections

261

910

1.44

6.58

2.2

2.7

1.21

1.17

ug/l

0.11

236

873

COPD/asthma related infections

261

910

1.44

6.58

2.2

2.7

1.21

1.17

ug/l

0.11

236

873

Other joint disorders

244

887

1.45

6.56

2.4

2.5

1.13

1.11

ug/l

0.08

225

839

Kela-code for severe mental illness

566

1.75

6.56

1.2

2.3

1.10

0.96

ug/l

0.29

516

Pneumonias (Asthma/COPD co-morbidities)

267

1268

1.41

6.54

2.2

2.7

1.24

1.20

ug/l

0.10

250

1196

Bronchitis

266

1182

1.42

6.54

2.1

2.6

1.21

1.13

ug/l

0.22

244

1124

Certain infectious and parasitic diseases

195

642

1.52

6.53

2.3

2.8

1.16

1.21

ug/l

0.10

178

609

Other disorders of ear

219

978

1.47

6.49

2.1

2.6

0.97

1.20

ug/l

1.11

208

923

Abnormal findings on examination of blood, without diagnosis

102

541

1.73

6.43

2.2

2.5

1.14

1.10

ug/l

0.07

512

Conductive and sensorineural hearing loss

166

723

1.55

6.42

2.0

2.5

1.03

1.09

ug/l

0.17

156

686

Pneumonia, organism unspecified

240

1173

1.44

6.42

2.1

2.7

1.33

1.21

ug/l

0.36

224

1107

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

261

1261

1.41

6.37

2.2

2.7

1.26

1.18

ug/l

0.24

244

1189

Chronic sinusitis

102

594

1.72

6.33

2.0

2.3

0.84

1.16

ug/l

1.59

560

Dental pulpitis, including avohilmo

244

1109

1.43

6.31

2.0

2.4

1.08

1.07

ug/l

0.03

222

1046

Bacterial infection, other or unspecified

122

632

1.63

6.12

2.2

2.7

1.19

1.17

ug/l

0.04

115

598

Endometriosis

253

1.88

6.11

1.7

2.1

1.44

1.17

ug/l

0.42

243

Cervical disc disorders

411

1.85

6.08

2.1

2.4

0.81

1.02

ug/l

0.63

390

Soft tissue disorders related to use, overuse and pressure

288

2.02

5.97

1.3

2.5

1.43

0.95

ug/l

0.85

274

Acute sinusitis

135

794

1.58

5.94

1.7

2.5

0.92

1.07

ug/l

0.46

122

755

Other benign neoplasms of skin

436

1.82

5.94

2.5

2.2

1.12

1.07

ug/l

0.09

409

Asthma, including avohilmo

304

1250

1.37

5.93

2.3

2.6

1.19

ug/l

0.02

280

1184

Other enthesopathies

337

1.93

5.92

1.8

2.4

0.81

0.99

ug/l

0.50

323

Substance abuse, excluding more controls

123

650

1.62

5.92

1.6

2.3

1.16

0.98

ug/l

0.45

111

605

Chronic lower respiratory diseases

315

1234

1.36

5.91

2.3

2.6

1.21

1.19

ug/l

0.05

293

1167

Noninfective enteritis and colitis

128

806

1.59

5.89

2.4

2.9

1.38

1.19

ug/l

0.48

120

757

Other and unspecified dermatitis

123

769

1.60

5.86

1.9

2.7

1.30

1.20

ug/l

0.23

114

737

Lumbar disc prolapse

143

704

1.56

5.85

2.0

2.3

0.72

1.10

ug/l

2.89

135

663

Artrosis, including avohilmo

193

714

1.48

5.83

2.5

2.1

1.03

1.01

ug/l

0.05

171

674

Shoulder lesions

162

642

1.53

5.83

2.2

2.3

0.91

1.01

ug/l

0.28

149

608

Other disorders of urethra and urinary system

156

740

1.52

5.69

2.0

2.5

1.00

1.17

ug/l

0.75

150

714

Arthropathies

251

906

1.40

5.67

2.6

1.17

1.13

ug/l

0.10

229

858

Other external causes of accidental injury

218

758

1.44

5.67

2.2

2.8

1.27

1.20

ug/l

0.20

202

721

Diseases of salivary glands

443

1.79

5.66

2.0

2.4

0.89

1.12

ug/l

0.50

417

Diseases of middle ear and mastoid

164

898

1.50

5.61

2.1

2.7

1.25

1.20

ug/l

0.10

152

836

Finngen Rheumatological endpoints

250

1019

1.40

5.60

2.2

2.4

1.11

1.10

ug/l

0.02

225

964

Emotionally unstable personality disorder

196

2.20

5.55

1.4

2.2

1.19

1.00

ug/l

0.27

178

Diseases of pulp and periapical tissues, including avohilmo

264

991

1.38

5.44

2.2

2.7

1.23

1.21

ug/l

0.06

247

942

Sciatica+with lumbago

111

634

1.61

5.41

1.7

2.4

0.78

1.16

ug/l

2.51

106

603

Cardiac arrhythmias

158

682

1.51

5.41

1.8

2.7

1.65

1.09

ug/l

1.10

148

646

Dental operations

136

444

1.58

5.40

2.3

1.16

1.21

ug/l

0.09

127

420

Viral infections characterized by skin and mucous membrane lesions

218

1330

1.40

5.37

2.5

2.6

1.09

1.22

ug/l

0.43

207

1256

External causes of morbidity and mortality

179

606

1.48

5.36

2.4

2.9

1.39

1.27

ug/l

0.29

164

578

Oxycodone

354

1.82

5.31

1.5

2.1

1.09

0.99

ug/l

0.15

337

Other disorders of skin and subcutaneous tissue

145

855

1.51

5.26

1.7

2.5

1.59

1.09

ug/l

1.59

139

811

Accidents

215

758

1.42

5.23

2.2

2.8

1.28

1.20

ug/l

0.21

197

721

Noninflammatory disorders of female genital tract

290

1.70

5.19

1.9

2.3

1.07

1.21

ug/l

0.35

279

Erysipelas

148

752

1.50

5.18

1.9

2.3

1.09

0.95

ug/l

0.33

138

700

Endometriosis of rectovaginal septum and vagina

3.14

5.18

1.4

2.2

1.44

1.18

ug/l

0.14

Disorders of synovium and tendon

122

687

1.56

5.12

2.0

2.5

1.43

1.12

ug/l

0.41

113

655

Other arthrosis

105

447

1.63

5.11

2.3

2.0

0.98

0.89

ug/l

0.28

423

Internal derangement of knee

500

1.69

5.10

1.4

2.1

1.00

0.96

ug/l

0.09

472

Paralytic strabismus

3.01

5.10

3.5

2.2

1.48

1.27

ug/l

0.12

Other diseases of urinary system

237

963

1.38

5.08

2.0

2.7

1.10

1.23

ug/l

0.43

223

922

Type of accident

444

1.74

5.06

1.8

2.6

1.63

1.14

ug/l

1.03

416

Disorders of conjunctiva

215

1241

1.39

5.06

2.4

2.6

1.30

1.24

ug/l

0.11

210

1165

Injuries to the knee and lower leg

293

1217

1.34

5.04

2.2

2.6

0.99

1.18

ug/l

0.85

273

1149

Hyperplasia of prostate

212

1.85

5.00

2.1

2.4

0.80

0.86

ug/l

0.10

200

267

1019

1.35

4.94

2.2

2.6

1.22

1.15

ug/l

0.20

243

976

Biguanides

209

909

1.40

4.92

2.2

1.12

1.05

ug/l

0.14

190

860

Bacterial infection, other or unspecified

106

578

1.59

4.92

2.2

2.7

1.29

1.13

ug/l

0.31

101

547

Any operation in hilmo

7.69

4.91

2.2

3.9

1.14

1.71

ug/l

—

Ovarian cyst

260

1.76

4.87

2.0

1.07

1.16

ug/l

0.22

250

Other intervertebral disc disorders

179

750

1.44

4.84

2.0

2.3

0.80

1.10

ug/l

1.96

169

703

Supplementary factors related to causes of morbidity and mortality classified elsewhere

488

1.68

4.83

1.8

2.6

1.68

1.10

ug/l

1.33

457

Other and unspecified polyneuropathies, also in other diseases

188

2.13

4.83

1.2

2.4

0.85

1.07

ug/l

0.48

177

Meniscus derangement

116

500

1.56

4.79

2.2

2.0

0.98

0.90

ug/l

0.24

109

472

Disorders of skin appendages

122

800

1.53

4.79

2.0

2.5

1.16

ug/l

0.00

116

752

Transport accidents

116

645

1.55

4.78

1.7

2.6

1.22

1.05

ug/l

0.34

109

608

Polyneuropathies and other disorders of the peripheral nervous system

236

2.00

4.77

1.3

2.5

1.12

1.23

ug/l

0.13

224

Adverse effects, not elsewhere classified

335

1.83

4.75

1.9

2.9

0.92

1.38

ug/l

1.37

315

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

14.51

4.61

7.6

4.0

2.91

1.61

ug/l

—

Hernia

217

1061

1.37

4.59

2.4

2.5

1.17

1.14

ug/l

0.05

200

997

Urticaria

526

1.64

4.58

2.6

2.9

1.26

1.38

ug/l

0.28

498

Other acute lower respiratory infections

132

847

1.49

4.58

2.5

2.8

1.16

1.21

ug/l

0.11

120

800

Disorders of gallbladder, biliary tract and pancreas

213

976

1.38

4.57

2.3

2.4

1.05

1.11

ug/l

0.15

200

924

Cholecystectomy

139

814

1.47

4.56

2.3

2.2

1.04

1.12

ug/l

0.17

130

776

Delayed milestone in childhood

132

2.31

4.56

5.5

5.9

2.58

2.22

ug/l

0.36

132

Congenital malformations, deformations and chromosomal abnormalities

171

1120

1.41

4.45

2.3

2.6

1.31

1.13

ug/l

0.65

162

1050

Cholelithiasis

165

798

1.43

4.42

2.3

2.2

1.08

1.12

ug/l

0.08

153

760

Other disorders of veins

475

1.66

4.41

1.7

2.2

0.80

0.99

ug/l

0.77

451

Covid-19 confirmed case

471

1.66

4.38

1.7

2.5

1.19

ug/l

0.00

442

Crossbite

212

1.98

4.37

6.3

4.8

1.32

1.73

ug/l

0.83

205

Slow fetal growth and fetal malnutrition

3.34

4.36

5.3

6.5

2.12

2.54

ug/l

0.26

Other disorders of eye and adnexa

210

2.01

4.35

3.0

2.9

1.55

1.37

ug/l

0.20

195

Any event in cancer register

226

984

1.35

4.33

2.2

2.5

1.20

1.14

ug/l

0.16

214

927

Diabetes medication

254

1134

1.33

4.32

2.3

2.5

1.20

1.09

ug/l

0.34

230

1072

Postviral fatigue syndrome

11.88

4.29

1.7

2.8

1.34

1.89

ug/l

—

Cholelithiasis, broad definition with cholecystitis

172

823

1.41

4.28

2.3

2.2

1.06

1.11

ug/l

0.11

159

783

Undescended testicle

3.12

4.27

6.6

5.9

2.01

2.04

ug/l

0.02

Coxarthrosis

364

1.62

4.24

3.2

1.9

1.11

0.94

ug/l

0.28

352

Conjunctivitis

195

1192

1.37

4.22

2.5

2.7

1.37

1.27

ug/l

0.19

190

1117

Other viral diseases

117

778

1.49

4.22

2.6

2.9

1.31

1.36

ug/l

0.09

111

731

Suppurative and unspecified otitis media

112

657

1.51

4.22

2.1

2.9

1.18

1.23

ug/l

0.08

102

608

Injuries to the wrist and hand

247

1293

1.32

4.22

2.0

2.6

1.11

1.15

ug/l

0.12

229

1223

Injury, poisoning and certain other consequences of external causes

148

509

1.46

4.22

2.1

3.0

1.35

1.38

ug/l

0.05

134

486

Disorders of orbit

3.43

4.18

2.6

2.4

0.96

1.13

ug/l

0.17

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

138

931

1.44

4.16

2.1

2.5

1.36

1.20

ug/l

0.23

133

877

Leisure time condition

263

1.87

4.15

1.8

2.7

1.68

1.25

ug/l

0.52

245

Infections of the skin and subcutaneous tissue

151

1057

1.42

4.13

2.4

2.7

1.15

1.19

ug/l

0.08

140

990

Malignant neoplasm of eye, brain and central nervous system

3.00

4.12

3.4

1.21

1.94

ug/l

0.63

Polyarthropathies

154

707

1.42

4.09

2.5

2.4

1.27

1.11

ug/l

0.39

145

672

Trigeminal neuralgia

3.09

4.08

1.4

1.8

1.59

1.18

ug/l

0.28

Dislocation, sprain and strain of joints and ligaments of knee

149

969

1.42

4.08

2.2

2.3

0.92

1.12

ug/l

0.60

139

904

Motor disorders, excluding more controls

2.76

4.07

5.7

6.0

2.60

1.72

ug/l

0.75

Rotator cuff syndrome

114

544

1.50

4.07

2.0

2.4

0.92

0.98

ug/l

0.14

106

518

Bleeding

176

904

1.39

4.06

2.0

2.6

1.29

1.09

ug/l

0.56

167

851

Haemorrhoids and perianal venous thrombosis

308

1.78

4.04

1.9

1.8

0.89

1.00

ug/l

0.20

290

Cystitis

187

812

1.37

3.92

2.1

2.6

1.19

1.22

ug/l

0.09

173

784

Acute bronchitis

584

1.55

3.91

2.2

2.9

1.13

1.27

ug/l

0.37

556

Obsessive-compulsive disorder

100

2.41

3.89

1.7

2.8

1.38

1.16

ug/l

0.16

Family history of other specific disorders

7.37

3.87

1.4

4.4

1.07

1.80

ug/l

—

Erysipelas

104

612

1.50

3.86

1.8

2.3

1.11

0.92

ug/l

0.41

567

Open wound of head

125

834

1.45

3.85

2.9

2.8

1.23

1.10

ug/l

0.29

119

772

Enlarged lymph nodes

172

2.04

3.83

2.1

3.3

1.10

1.14

ug/l

0.05

163

Allergic rhinitis

633

1.52

3.80

2.5

3.1

0.96

1.41

ug/l

1.11

604

Hyperprolactinaemia, drug-induced

12.31

3.78

1.5

2.2

1.36

1.86

ug/l

—

Acute suppurative otitis media

538

1.55

3.77

2.2

3.0

1.10

1.30

ug/l

0.57

501

Congenital malformations, deformations and chromosomal abnormalities

156

1076

1.38

3.73

2.4

2.6

1.35

1.15

ug/l

0.67

149

1005

Gonarthrosis [arthrosis of knee](FG)

144

591

1.42

3.69

2.2

2.1

1.08

0.96

ug/l

0.21

133

564

Personal history of other diseases and conditions

251

1.83

3.69

5.0

3.7

2.16

1.43

ug/l

1.23

239

Malignant neoplasm of brain, including Hilmo

2.80

3.69

4.4

3.1

1.17

1.70

ug/l

0.36

Implicit fungal Sepsis

2.70

3.65

2.4

2.2

1.99

1.26

ug/l

0.56

ILD medications: immunosuppressive drugs

154

1038

1.38

3.64

2.1

2.8

1.33

1.19

ug/l

0.37

144

984

Other or unspecified ileus, impaction or obstruction

162

2.04

3.63

2.6

2.0

1.13

1.10

ug/l

0.04

155

Fall on and from stairs and steps

343

1.69

3.60

1.9

2.5

1.13

ug/l

0.01

321

Other congenital malformations

271

1.78

3.51

2.7

3.7

1.63

1.59

ug/l

0.05

256

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

214

980

1.32

3.51

2.2

2.6

1.26

1.14

ug/l

0.24

197

923

Appendectomy

150

1045

1.37

3.49

2.0

2.3

1.19

1.06

ug/l

0.27

139

976

Pain associated with micturition

145

2.08

3.46

1.7

3.0

1.04

1.25

ug/l

0.32

135

Keratitis

527

1.54

3.44

2.0

2.4

0.99

1.09

ug/l

0.18

494

Other specified congenital malformation syndromes affecting multiple systems

2.80

3.44

3.8

5.6

2.12

2.37

ug/l

0.13

Mental and behavioural disorders due to psychoactive substance use

131

869

1.40

3.38

1.6

2.2

1.14

0.94

ug/l

0.58

119

799

Malignant neoplasm of adrenal gland, including Hilmo

7.15

3.38

2.1

5.3

1.88

1.84

ug/l

—

136

2.10

3.37

5.5

5.6

2.47

2.29

ug/l

0.18

136

Malignant neoplasm of brain

3.12

3.37

3.5

3.4

0.60

1.69

ug/l

2.22

Diseases of liver

436

1.58

3.33

2.1

2.4

1.13

0.98

ug/l

0.24

408

Viral infections characterized by skin and mucous membrane lesions

104

718

1.45

3.31

2.7

2.8

1.04

1.24

ug/l

0.54

677

Allergic conjunctivitis

141

1001

1.37

3.31

2.1

2.6

1.34

1.21

ug/l

0.20

136

947

Gingivitis and periodontal diseases

238

952

1.29

3.31

2.7

2.5

1.25

1.15

ug/l

0.32

224

898

Other disorders of kidney and ureter

155

2.01

3.29

2.0

2.5

1.85

1.33

ug/l

0.51

144

Hypoglycaemia, other or unspecified

115

2.18

3.28

3.2

3.4

3.25

1.63

ug/l

1.15

106

Injuries to the abdomen, lower back, lumbar spine and pelvis

536

1.52

3.26

1.8

2.4

1.32

1.07

ug/l

0.65

505

Chronic diseases of tonsils and adenoids

193

926

1.32

3.25

2.6

2.7

1.30

1.25

ug/l

0.13

181

870

Other and unspecified tonsillitis

103

599

1.45

3.20

2.8

2.9

1.26

1.11

ug/l

0.30

564

Persons encountering health services in circumstances related to reproduction

165

829

1.34

3.18

3.4

2.6

1.31

1.16

ug/l

0.38

157

765

Abnormal involuntary movements

172

1.92

3.13

2.3

2.7

1.74

1.11

ug/l

0.55

159

151

1.99

3.13

5.5

5.4

2.36

2.18

ug/l

0.19

151

Sequelae of injuries of head

2.55

3.12

1.6

2.4

0.86

1.08

ug/l

0.27

Other disorders of nervous system

2.55

3.12

2.0

2.6

1.22

1.15

ug/l

0.04

Other congenital malformations

208

1.83

3.11

2.8

4.0

1.79

1.66

ug/l

0.14

199

Propionic acid derivatives

213

1.61

3.09

2.5

3.4

1.09

1.04

ug/l

0.07

206

Hypermetropia

152

1.98

3.08

3.7

4.3

1.82

1.58

ug/l

0.24

144

Other disorders of glucose regulation and pancreatic internal secretion

132

2.05

3.06

3.4

3.20

1.58

ug/l

1.29

122

Single delivery by forceps and vacuum extractor

192

0.38

3.05

1.2

1.8

2.34

0.94

ug/l

1.22

179

Other viral diseases

606

1.47

3.04

2.4

3.1

1.27

1.37

ug/l

0.19

573

Exposure to other specified factors

183

1290

1.30

3.03

2.3

2.6

0.97

1.17

ug/l

0.76

172

1213

Portal vein thrombosis

5.89

3.03

2.3

4.1

3.08

1.20

ug/l

—

Dental caries, including avohilmo

164

626

1.34

3.02

2.8

2.7

1.22

1.31

ug/l

0.23

156

594

Turner's syndrome

10.45

3.01

7.0

4.2

2.93

2.23

ug/l

—

Necrosis of pulp, including avohilmo

135

992

1.36

3.01

2.6

2.2

1.27

1.07

ug/l

0.43

124

930

All influenza

377

1.59

3.00

2.8

3.2

1.00

1.25

ug/l

0.75

353

Other and unspecified disorders of autonomic nervous system

10.28

3.00

1.0

2.2

1.71

1.17

ug/l

—

Neuroendocrine tumor and carcinoma of pancreas

10.19

2.99

4.6

2.2

0.57

1.15

ug/l

—

Venous thromboembolism

597

1.46

2.98

1.5

2.3

0.97

1.03

ug/l

0.14

564

Mental disorders, not otherwise specified

120

2.09

2.98

1.5

2.2

1.10

1.02

ug/l

0.06

110

Nonsuppurative otitis media

408

1.53

2.96

2.9

3.0

2.01

1.36

ug/l

1.02

383

Coxarthrosis [arthrosis of hip](FG)

438

1.46

2.94

3.1

2.1

1.11

0.94

ug/l

0.31

422

Other specified and unspecified strabismus

4.77

2.93

3.6

4.1

0.81

1.37

ug/l

—

Anti-inflammatory and antirheumatic products, non-steroids

213

1.58

2.90

2.5

3.4

1.10

1.04

ug/l

0.11

206

Extracorporeal dialysis

2.38

2.89

2.6

2.9

2.85

1.52

ug/l

0.81

Redundant prepuce, phimosis and paraphimosis

309

1.64

2.85

2.3

2.7

1.02

0.89

ug/l

0.18

280

Excessive attrition of teeth

134

997

1.35

2.83

2.3

2.5

1.17

1.23

ug/l

0.12

127

941

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

416

1.54

2.80

1.8

2.4

0.80

0.97

ug/l

0.49

382

Cluster headache, strict, including avohilmo

2.41

2.80

2.0

2.4

0.44

1.06

ug/l

2.35

Diseases of pulp and periapical tissues and dental caries

146

557

1.34

2.76

2.7

1.36

1.33

ug/l

0.06

139

527

Benign intracranial hypertension

6.07

2.70

1.5

2.1

0.97

1.82

ug/l

—

Anorexia (incl.atypical)

2.24

2.70

1.6

2.5

1.24

1.10

ug/l

0.16

Gonarthrosis

116

478

1.38

2.69

2.1

2.0

1.20

0.95

ug/l

0.40

106

454

Oxicams

116

1.81

2.69

2.3

2.1

0.68

0.89

ug/l

0.41

109

Specific developmental disorder of motor function

2.21

2.68

5.7

6.1

2.60

1.70

ug/l

0.80

Certain conditions originating in the perinatal period

220

1.70

2.67

4.9

4.1

1.67

1.59

ug/l

0.10

213

Cluster headache, wide,, including avohilmo

2.34

2.65

2.0

2.4

0.44

1.03

ug/l

2.23

Undescended testis, unilateral

3.00

2.65

7.0

6.2

1.90

2.22

ug/l

0.18

Rosacea

140

1.93

2.64

1.7

2.1

1.11

1.13

ug/l

0.01

131

Diseases of arteries, arterioles and capillaries

108

577

1.38

2.63

2.0

2.2

1.81

0.96

ug/l

1.32

102

544

Mycoses

190

1302

1.27

2.62

2.2

2.4

1.32

1.10

ug/l

0.77

176

1226

Neuromuscular dysfunction of bladder

2.16

2.60

2.0

2.3

0.88

1.09

ug/l

0.31

Special screening examination for infectious and parasitic diseases

245

1.60

2.59

2.2

2.1

1.75

1.01

ug/l

1.22

221

Nephropathy related operations

177

1.81

2.59

2.6

3.2

2.74

1.36

ug/l

1.58

164

Other congenital malformations of nervous system

3.66

2.59

7.0

4.8

1.79

1.84

ug/l

—

Pollen allergy

459

1.49

2.58

2.6

3.4

1.04

1.51

ug/l

0.79

436

Other osteochondrodysplasias

4.07

2.58

3.6

5.5

0.37

2.47

ug/l

—

Arnold-Chiari syndrome

4.07

2.58

7.7

4.8

1.86

2.14

ug/l

—

Substance abuse

123

862

1.34

2.57

1.6

2.2

1.16

0.94

ug/l

0.61

111

792

Other diseases of hard tissues of teeth

124

473

1.36

2.54

2.3

2.5

1.15

1.30

ug/l

0.36

114

447

Anosmia

6.97

2.50

2.0

1.4

0.33

0.58

ug/l

—

Maxillary retrognathism

3.00

2.49

6.6

4.5

0.80

1.28

ug/l

0.86

Pain in thoracic spine

172

1.81

2.49

2.0

2.4

0.55

1.15

ug/l

2.82

158

Diseases of appendix

163

1146

1.28

2.47

2.0

2.2

1.16

1.04

ug/l

0.29

152

1071

Other disorders involving the immune mechanism, not elsewhere classified

2.68

2.45

2.6

3.7

1.28

1.69

ug/l

0.23

Dialysis, with operation codes

173

1.80

2.45

2.9

3.2

2.75

1.36

ug/l

1.57

162

Gonarthrosis, primary, with knee surgery

484

1.42

2.45

1.9

2.1

0.93

1.11

ug/l

0.49

462

Atrial fibrillation and flutter with reimbursement

141

1.72

2.40

1.9

1.44

0.68

ug/l

1.14

132

Excessive earwax

105

756

1.36

2.39

2.4

2.6

1.27

1.15

ug/l

0.29

719

Haemorrhage, not elsewhere classified

3.35

2.39

1.8

3.1

1.06

1.62

ug/l

—

LeFortI or BSSO operation

2.36

2.39

3.5

2.4

0.73

1.00

ug/l

0.53

Cerebrovascular diseases

121

637

1.34

2.38

2.1

2.3

1.14

0.99

ug/l

0.36

112

604

Other skin changes

212

1.70

2.38

1.9

2.6

1.52

1.10

ug/l

0.56

201

STROKE

104

517

1.37

2.38

2.4

1.26

0.97

ug/l

0.71

486

Bilateral cryptorchidism (undescended testicles)

3.75

2.34

6.5

6.6

2.29

3.06

ug/l

—

Diabetes, insulin treatment (Kela reimbursement)

218

1064

1.24

2.34

2.2

2.6

1.24

1.11

ug/l

0.27

201

1000

Gonarthrosis,primary

150

714

1.29

2.33

2.0

2.2

0.81

1.03

ug/l

1.13

139

677

Artificial joint operation, meniscal resection

166

846

1.27

2.31

2.0

2.2

0.98

0.96

ug/l

0.04

156

794

Care involving dialysis

112

1.97

2.30

3.0

3.3

2.90

1.45

ug/l

1.20

106

Other/unspecified synovitis and tenosynovitis

126

1.91

2.30

1.2

2.8

1.04

0.96

ug/l

0.09

121

Open wound of wrist and hand

105

764

1.34

2.28

1.7

2.4

0.95

1.08

ug/l

0.34

703

Transplanted organ and tissue status

148

1.83

2.28

3.4

3.6

2.80

1.40

ug/l

1.94

138

Appendicitis, broad definition

160

1141

1.27

2.26

2.0

2.2

1.17

1.04

ug/l

0.30

149

1067

Congenital malformations and deformations of the musculoskeletal system

230

1.65

2.25

3.4

4.2

1.29

1.74

ug/l

0.95

222

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

190

975

1.25

2.23

2.2

2.3

1.39

1.04

ug/l

0.79

177

923

Injuries to the ankle and foot

174

1234

1.25

2.22

2.0

2.7

1.20

1.16

ug/l

0.09

162

1161

Varus deformity, not elsewhere classified

5.61

2.22

5.0

3.6

1.51

1.30

ug/l

—

Other heart diseases

117

576

1.33

2.21

2.0

3.1

1.64

1.14

ug/l

1.22

108

543

Other heart diseases, wide

224

1119

1.22

2.19

2.0

2.7

1.54

1.13

ug/l

1.04

208

1055

DVT of lower extremities and pulmonary embolism

439

1.45

2.19

1.5

2.2

0.82

1.01

ug/l

0.49

412

Disorders of sclera, cornea, iris and ciliary body

113

857

1.32

2.19

2.4

1.08

1.13

ug/l

0.08

104

801

Other noninflammatory disorders of vulva and perineum

2.07

2.16

1.9

2.0

1.35

1.26

ug/l

0.07

Injuries to the shoulder and upper arm

173

1115

1.25

2.15

1.8

2.5

1.10

1.06

ug/l

0.08

160

1042

Caries of enamel

211

1243

1.23

2.14

2.8

2.5

1.36

1.16

ug/l

0.64

200

1165

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

2.36

2.12

1.9

2.7

1.35

1.32

ug/l

0.02

Hernia of abdominal wall

621

1.37

2.11

2.0

2.5

1.15

1.04

ug/l

0.18

585

Other and unspecified injuries of ankle and foot

2.22

2.11

1.9

3.0

2.24

1.13

ug/l

1.13

Primary_lymphoid and hematopoietic malignant neoplasms

267

1.58

2.10

2.1

2.7

1.00

1.20

ug/l

0.36

249

Ischemic heart diseases

168

803

1.26

2.10

2.3

2.7

1.30

1.08

ug/l

0.64

161

755

Routine general health check-up of defined subpopulation

3.22

2.09

2.8

3.1

6.11

1.16

ug/l

—

Acute appendicitis

150

1110

1.26

2.09

2.1

2.2

1.17

1.03

ug/l

0.31

140

1037

Second line medication for Crohn's disease

126

977

1.29

2.08

2.2

2.7

1.32

1.18

ug/l

0.36

119

920

Open wound of neck

5.06

2.08

1.0

3.1

0.52

1.88

ug/l

—

Open bite that required surgery (Lefort1 or BSSO)

5.05

2.07

1.0

2.3

0.93

1.68

ug/l

—

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

5.03

2.07

1.0

2.4

0.97

1.27

ug/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

5.03

2.07

1.0

1.8

0.71

1.15

ug/l

—

Non-Hodgkin lymphoma, all, including Hilmo

124

1.86

2.06

2.4

2.5

0.93

1.10

ug/l

0.20

112

Monoamine oxidase A inhibitors

117

1.88

2.05

1.2

2.2

0.62

1.12

ug/l

1.29

106

Diseases of oral cavity, salivary glands and jaws

121

475

1.31

2.04

2.3

2.5

1.26

1.31

ug/l

0.08

114

449

Other abnormal findings in urine

4.03

2.04

2.0

2.9

1.57

1.81

ug/l

—

Other congenital malformations of male genital organs

2.56

2.04

6.5

6.0

1.86

2.19

ug/l

0.21

L04AX Other immunosuppressants

122

946

1.29

2.03

2.2

2.7

1.29

1.20

ug/l

0.20

115

894

Hard cardiovascular diseases

173

828

1.25

2.02

2.4

2.8

1.40

1.07

ug/l

1.08

164

779

Hypoplasia of dental enamel

2.05

2.02

4.6

6.5

2.83

2.01

ug/l

0.55

Unspecified fall

107

804

1.31

2.01

2.4

2.9

0.94

1.24

ug/l

1.50

102

756

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

2.52

2.01

2.7

3.8

1.36

1.61

ug/l

0.12

Osteonecrosis

2.23

2.01

1.8

2.2

0.85

1.25

ug/l

0.56

Monosomies and deletions from the autosomes, not elsewhere classified

3.50

2.00

3.7

6.3

4.07

2.68

ug/l

—

Coxarthrosis, primary

544

1.35

1.99

3.3

2.1

1.18

1.03

ug/l

0.25

523

Central nervous system disorder causing precocious puberty

4.72

1.96

3.6

6.2

0.84

1.71

ug/l

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

469

1.41

1.96

1.4

2.5

1.22

1.19

ug/l

0.03

436

Melanocytic naevi, other sites/unspecified

105

1.91

1.95

2.4

2.2

1.23

1.10

ug/l

0.16

Allergic asthma (mode)

354

1.47

1.94

2.5

3.0

1.46

1.20

ug/l

0.26

336

L01XX Other antineoplastic agents

2.45

1.93

2.5

1.7

1.21

1.36

ug/l

0.14

Periapical abscess

728

1.32

1.90

2.2

2.6

1.03

1.13

ug/l

0.22

680

Sudden idiopathic hearing loss

1.92

1.90

1.6

2.0

0.58

1.14

ug/l

1.56

Other and unspecified rosacea

1.96

1.89

1.3

1.8

1.31

1.34

ug/l

0.01

Motor disorders

107

1.89

1.85

5.7

6.1

2.60

1.92

ug/l

0.54

107

Allergic asthma (mode), excluding more controls

358

1.45

1.85

2.5

3.0

1.46

1.17

ug/l

0.29

340

Personal history of risk-factors, not elsewhere classified

3.56

1.84

3.2

1.47

2.94

ug/l

—

Other diseases of stomach and duodenum

2.21

1.84

1.5

1.7

1.51

1.02

ug/l

0.23

Caries of dentine, including avohilmo

167

689

1.24

1.83

2.6

2.7

1.26

1.32

ug/l

0.16

159

654

Other maternal disorders predominantly related to pregnancy

118

576

1.29

1.82

2.0

2.2

1.19

1.24

ug/l

0.11

112

556

Fracture of lower leg, including ankle

109

839

1.29

1.81

2.1

2.4

1.13

ug/l

0.00

102

785

Mandibular prognathia

2.59

1.80

7.2

5.1

1.09

1.73

ug/l

—

Calculus of lower urinary tract

2.27

1.80

3.3

1.7

0.56

1.18

ug/l

1.33

Other congenital malformations of male genital organs

2.39

1.80

6.5

5.9

1.86

2.16

ug/l

0.19

Labour and delivery complicated by fetal stress [distress]

330

0.63

1.79

2.1

1.41

1.16

ug/l

0.30

313

Atopic dermatitis

145

956

1.24

1.78

2.7

1.21

1.24

ug/l

0.06

137

905

Other acquired deformities of musculoskeletal system and connective tissue

2.35

1.77

1.7

2.1

1.15

0.89

ug/l

0.22

Complications associated with artificial fertilization

3.35

1.75

1.5

2.6

1.14

1.37

ug/l

—

Agranulocytosis

147

1.70

1.73

2.1

2.7

1.52

1.50

ug/l

0.01

138

Iron deficiency anaemia secondary to blood loss (chronic)

155

1.68

1.72

1.4

2.5

1.62

1.14

ug/l

0.37

148

Malignant neoplasm, wide definition for exclusion

193

938

1.21

1.71

2.5

1.24

1.12

ug/l

0.29

183

879

Cholangitis (primary sclerosing, PSC)

2.01

1.69

2.5

3.1

3.37

1.61

ug/l

0.78

Focal epilepsy, mode (most common among epilepsy diagnosis)

291

1.48

1.68

3.6

3.3

1.56

1.29

ug/l

0.30

272

Injuries to the elbow and forearm

151

1083

1.23

1.67

2.1

2.6

1.39

1.14

ug/l

0.73

142

1020

Dipeptidyl peptidase 4 (DPP-4) inhibitors

489

1.33

1.66

1.9

2.2

0.90

0.96

ug/l

0.10

467

Other diseases of lip and oral mucosa

572

1.33

1.63

1.4

2.5

1.22

1.14

ug/l

0.12

542

Acute appendicitis, no complications

120

955

1.25

1.63

2.1

2.3

1.05

1.06

ug/l

0.01

113

888

Benign neoplasm: Lip

3.59

1.61

4.2

2.2

0.81

0.99

ug/l

—

Respiratory and cardiovascular disorders specific to the perinatal period

155

1.63

1.61

6.1

5.7

2.36

2.14

ug/l

0.19

155

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

2.57

1.61

5.8

6.1

1.94

2.32

ug/l

—

Chronic respiratory disease originating in the perinatal period

3.13

1.60

6.2

5.8

2.58

2.68

ug/l

—

Macular pucker

128

1.72

1.60

2.3

1.8

0.66

1.10

ug/l

0.95

120

Acute bronchiolitis

192

1.55

1.59

4.9

4.6

1.99

1.87

ug/l

0.09

185

Disease of hard tissues of teeth, NOS

109

447

1.28

1.59

2.0

2.3

1.18

1.22

ug/l

0.06

421

Outcome of delivery

203

0.58

1.57

2.7

1.9

1.22

1.05

ug/l

0.16

192

Other and unspecified urticaria

346

1.42

1.56

2.8

3.0

1.33

1.36

ug/l

0.04

325

Inflammatory diseases of prostate (prostatitis)

114

1.76

1.56

2.2

2.4

0.62

0.65

ug/l

0.04

108

Hypospadias

3.41

1.53

5.4

6.1

1.80

3.44

ug/l

—

Coarctation of the aorta

0.00

1.53

0.0

5.3

—

2.06

—

Somnolence

3.36

1.52

3.4

2.3

0.33

1.43

ug/l

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

2.62

1.52

6.3

5.8

0.68

1.57

ug/l

—

Myositis

2.87

1.50

1.5

3.5

0.52

1.11

ug/l

—

Benign neoplasm: Skin of other and unspecified parts of face

101

1.79

1.48

2.4

1.9

0.48

1.30

ug/l

3.25

Varicose veins

537

1.28

1.47

2.8

2.1

1.42

1.01

ug/l

0.48

514

Disorders of tooth development and eruption

242

1.44

1.46

4.2

2.7

1.27

1.33

ug/l

0.09

229

Family history of malignant neoplasm

132

1.67

1.45

3.3

2.2

1.54

1.00

ug/l

0.56

121

Coagulation defects, purpura and other haemorrhagic conditions

293

1.44

1.45

1.9

2.9

1.35

1.21

ug/l

0.14

276

Suggestive for eosinophilic asthma

102

1.77

1.44

2.4

2.1

0.71

1.16

ug/l

0.96

Polyarteritis nodosa and related conditions

3.14

1.44

1.2

4.1

2.38

2.20

ug/l

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

1.92

1.43

1.2

2.2

0.77

1.07

ug/l

0.44

Injury of muscle and tendon at shoulder and upper arm level

412

1.36

1.43

1.3

2.3

0.88

0.95

ug/l

0.13

385

Assault by bodily force

125

1.68

1.43

2.0

2.6

1.45

0.98

ug/l

0.36

114

Non-rheumatic valve diseases

439

1.30

1.42

2.3

3.0

1.50

1.11

ug/l

0.69

417

Statin medication

149

692

1.21

1.42

2.5

2.2

1.07

1.16

ug/l

0.20

137

650

5-aminosalicylic acid

328

1.40

1.42

2.1

2.7

1.32

1.19

ug/l

0.26

306

Fracture of shoulder and upper arm

517

1.31

1.40

2.2

2.8

1.65

1.16

ug/l

0.90

485

Perineal laceration during delivery

273

0.61

1.39

2.1

1.99

1.02

ug/l

0.78

256

Fracture of lumbar spine and pelvis

213

1.50

1.39

1.3

2.2

1.72

1.15

ug/l

0.98

200

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

2.08

1.38

3.6

2.8

0.69

1.63

ug/l

1.18

Pre-eclampsia or eclampsia

305

1.41

1.37

1.5

2.2

1.21

1.26

ug/l

0.08

289

Thrombocytopenia, unspecified

1.80

1.37

1.4

2.7

1.15

1.54

ug/l

0.50

Purpura and other haemorrhagic conditions

198

1.52

1.37

1.9

3.0

1.14

1.39

ug/l

0.34

184

Hypoplasia of dental enamel, prenatal , including avohilmo

2.20

1.36

4.9

6.3

3.18

2.38

ug/l

—

Prominent ears

2.96

1.36

1.8

5.3

2.40

1.22

ug/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

115

740

1.23

1.36

1.9

2.2

1.39

1.12

ug/l

0.66

107

709

Congenital malformations of cardiac chambers and connections

0.00

1.35

0.0

6.1

—

1.65

—

Pre-eclampsia

281

1.43

1.35

1.5

2.2

1.18

1.24

ug/l

0.08

266

Disorders of muscles

112

1.70

1.35

1.6

2.9

0.63

1.08

ug/l

1.24

107

Hypoplasia of dental enamel, prenatal

2.45

1.32

4.5

6.3

3.85

2.49

ug/l

—

Chronic periodontitis, including avohilmo

182

1038

1.18

1.31

2.5

2.1

1.06

1.05

ug/l

0.01

172

968

Psoriasis

368

1.36

1.30

2.8

2.3

1.20

0.93

ug/l

0.28

343

Insulin, intermediate and long-acting

102

803

1.23

1.29

2.3

2.7

1.72

1.05

ug/l

1.05

751

Fall on same level involving ice and snow

105

854

1.23

1.29

2.2

2.3

1.10

1.07

ug/l

0.05

806

Asthma/COPD (KELA code 203)

208

1229

1.16

1.29

2.4

2.6

1.32

1.19

ug/l

0.35

193

1163

Cyst of kidney

1.89

1.28

1.3

1.8

0.60

1.29

ug/l

1.04

Drug-induced neutropenia

1.89

1.28

1.5

1.9

0.57

1.25

ug/l

1.68

Periodontitis

182

1039

1.17

1.27

2.5

2.1

1.06

1.05

ug/l

0.01

171

969

Valvular heart disease excluding rheumatic fever

454

1.27

2.4

3.1

1.50

1.16

ug/l

0.60

432

Other disorders of bone

302

1.39

1.26

1.5

2.5

0.73

1.04

ug/l

0.94

280

Pre-eclampsia or poor fetal growth

490

1.30

1.26

1.8

2.2

1.08

1.30

ug/l

0.63

465

Noninfectious colitis NAS

186

1.51

1.26

3.0

1.52

1.41

ug/l

0.12

172

Coxarthrosis, primary, with hip surgery

419

1.32

1.25

4.1

2.1

1.38

0.98

ug/l

0.61

404

Provisional assignment of new diseases of uncertain etiology

104

848

1.22

1.24

2.1

2.5

1.13

1.27

ug/l

0.33

799

Seborrhoeic dermatitis

123

1.63

1.23

1.8

2.8

1.90

1.17

ug/l

0.42

114

Allergic colitis

1.77

1.23

4.9

5.7

3.06

2.06

ug/l

0.41

Other inflammation of eyelid

171

1.52

1.23

2.1

3.0

0.86

1.31

ug/l

0.69

160

Striking against or struck by other objects

635

1.26

1.22

2.3

2.8

1.56

1.17

ug/l

0.79

584

Codes for special purposes

104

850

1.22

2.1

2.5

1.13

1.27

ug/l

0.33

801

Contusion of other and unspecified parts of foot

1.73

1.21

2.8

3.3

1.15

1.40

ug/l

0.28

Postmenopausal atrophic vaginitis

134

1.44

1.17

1.5

2.0

1.32

1.13

ug/l

0.26

127

Phakomatoses, not elsewhere classified

2.52

1.15

2.0

3.7

0.37

1.76

ug/l

—

Anxious personality disorder

2.51

1.15

1.0

2.6

2.01

1.22

ug/l

—

Thyroiditis

1.73

1.15

1.7

2.2

2.07

1.02

ug/l

0.74

Other chromosome abnormalities, not elsewhere classified

2.39

1.14

4.9

6.5

2.00

2.43

ug/l

—

Fracture of forearm

107

811

1.21

1.13

2.1

2.6

1.46

1.14

ug/l

0.79

101

766

Complications of labour and delivery

566

0.80

1.13

1.9

2.1

1.24

1.19

ug/l

0.08

547

Other and unspecified coagulation defects

1.79

1.11

1.7

2.8

1.72

1.11

ug/l

0.24

Multiple myeloma, including Hilmo

2.26

1.10

1.1

1.8

1.04

1.70

ug/l

—

Pedal cyclist injured in other and unspecified transport accidents

168

1.49

1.09

1.5

2.7

0.93

1.22

ug/l

0.42

152

Car occupant injured in other and unspecified transport accidents

294

1.36

1.09

1.6

2.3

1.13

1.23

ug/l

0.13

273

Other disorders of white blood cells

1.82

1.09

1.4

2.5

1.02

1.62

ug/l

0.85

Recurrent dislocation of patella

1.82

1.09

1.9

2.8

1.17

0.96

ug/l

0.16

Benign neoplasm: Transverse colon

112

1.61

1.08

6.9

1.8

1.03

1.11

ug/l

0.08

104

Congenital ovarian cysts

1.87

1.07

1.0

2.3

0.77

1.16

ug/l

0.45

Mycoses

356

1.32

1.06

2.0

2.5

1.01

1.15

ug/l

0.32

334

Unspecified dementia

1.87

1.06

1.5

1.3

1.93

1.12

ug/l

0.30

Ectopic testis

2.00

1.05

6.3

6.0

2.11

2.13

ug/l

—

Injury of nerves and spinal cord at neck level

2.28

1.03

1.0

1.9

2.01

0.91

ug/l

—

Undefined dementia

1.84

1.03

1.5

1.4

1.93

1.40

ug/l

0.18

Benign neoplasm of eye and adnexa

106

1.61

1.02

2.2

2.0

3.51

1.10

ug/l

0.58

Pedal cyclist injured in transport accident

359

1.31

1.01

1.8

2.6

1.36

1.14

ug/l

0.30

335

Mental and behavioural disorders due to cannabinoids

1.89

1.01

1.0

2.4

1.28

1.06

ug/l

—

Retinal breaks without detachment

172

1.46

0.99

3.3

2.3

0.45

0.92

ug/l

3.07

162

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

115

1.57

0.99

1.1

2.1

0.93

1.05

ug/l

0.19

108

Conduction disorders

277

1.32

0.99

1.6

2.9

1.33

1.09

ug/l

0.21

265

114

849

1.18

0.99

1.6

2.2

1.15

0.92

ug/l

0.56

103

779

Primary gonarthrosis, bilateral

475

1.24

0.99

1.9

2.2

0.94

1.02

ug/l

0.17

453

Congenital aortic valve stenosis

2.21

0.98

7.2

5.4

4.49

2.53

ug/l

—

Retinal detachment with retinal break

132

0.53

0.98

5.1

2.2

0.56

1.12

ug/l

—

123

Idiopathic urticaria

2.18

0.98

1.2

2.4

2.08

1.35

ug/l

—

Other disorders of conjunctiva

156

1.48

0.98

1.9

2.4

0.79

1.26

ug/l

1.01

143

Pervasive developmental disorders excl. Autism + Asperger

1.76

0.98

5.0

6.0

1.99

1.87

ug/l

0.08

Cardiodefibrillation

343

1.31

0.97

2.1

2.2

1.04

1.03

ug/l

0.01

322

Insulin medication

111

791

1.18

0.95

2.2

2.7

1.62

1.09

ug/l

0.82

104

749

Malignant melanoma of skin, including Hilmo

133

1.51

0.94

2.1

1.02

1.01

ug/l

0.01

122

IgA nephropathy (IgA glomerulonephritis)

2.23

0.93

2.5

1.8

1.87

0.79

ug/l

—

Recurrent dislocation and subluxation of joint

1.62

0.93

3.5

2.0

0.63

0.92

ug/l

0.61

Perforation of tympanic membrane

143

0.56

0.93

2.1

2.9

1.35

1.23

ug/l

—

134

Insulin, combination of fast acting with intermediate-acting or long-acting

111

863

1.18

0.92

2.2

2.7

1.62

1.08

ug/l

0.86

104

811

Otitis externa, unspecified

167

1.44

0.91

1.7

3.1

0.85

1.36

ug/l

1.27

156

conjunctival haemorrhage

1.67

0.91

1.7

2.4

0.95

1.65

ug/l

0.82

Other inflammatory liver diseases

1.67

0.91

1.2

2.5

2.17

1.22

ug/l

0.42

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

117

1.54

0.90

5.9

2.18

2.48

ug/l

0.27

117

Other diseases of biliary tract

1.63

0.90

1.9

2.4

1.10

1.64

ug/l

0.56

Hordeolum and other deep inflammation of eyelid

1.60

0.90

2.9

3.4

0.89

1.48

ug/l

0.93

Respiratory distress of newborn

125

1.50

0.90

5.9

6.0

2.59

2.38

ug/l

0.15

125

Multiple delivery

127

0.55

0.88

1.9

1.8

0.37

1.11

ug/l

—

120

Sacroiliitis, not elsewhere classified

1.79

0.87

3.7

2.8

0.64

1.17

ug/l

—

Squamous cell neoplasms and carcinomas of the skin

1.86

0.87

1.6

1.14

1.46

ug/l

—

Stroke, including SAH

534

1.20

0.87

2.2

2.3

1.28

0.96

ug/l

0.76

505

Vascular dementia

1.84

0.86

1.3

2.00

1.06

ug/l

—

Stroke, excluding SAH

485

1.20

0.85

2.3

1.28

0.97

ug/l

0.63

462

Retained placenta and membranes, without haemorrhage

167

0.60

0.84

1.7

2.1

1.13

1.09

ug/l

—

158

Varicella [chickenpox]

1.57

0.84

1.9

4.2

0.60

1.73

ug/l

3.57

Other congenital malformations of skin

137

1.46

0.84

2.3

3.4

1.35

1.54

ug/l

0.21

129

Other dialysis

1.74

0.82

3.6

3.1

2.41

1.18

ug/l

—

Malignant neoplasm of pancreas, including Hilmo

1.65

0.81

3.4

1.8

0.83

1.27

ug/l

0.65

Familial hypercholesterolemia, with ischemic heart disease

1.65

0.81

1.0

1.7

1.30

1.12

ug/l

0.09

Malignant melanoma of skin

105

1.53

0.81

2.4

1.9

1.22

1.04

ug/l

0.20

Abdominal aortic aneurysm (AAA)

1.74

0.81

2.8

1.5

0.41

0.76

ug/l

—

Varicella [chickenpox]

138

1.45

0.81

2.5

4.6

1.22

1.68

ug/l

0.47

132

Other mental disorders due to brain damage and dysfunction and to physical disease

1.55

0.81

4.1

1.8

1.17

0.92

ug/l

0.39

Myocardial infarction, strict

372

0.78

0.80

2.2

2.3

1.40

0.94

ug/l

0.57

348

Other and unspecified mental retardation

1.58

0.79

4.3

5.9

1.37

2.42

ug/l

1.92

Congenital malformations of larynx

0.00

0.79

0.0

6.1

—

2.47

—

Pneumonia due to other infectious organisms, not elsewhere classified

1.67

0.78

2.3

2.5

0.32

1.21

ug/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

106

1.51

0.78

3.3

2.1

0.63

0.86

ug/l

0.50

Meningitis

1.67

0.78

5.6

2.5

0.87

1.41

ug/l

0.74

Myocardial infarction, with ST-elevation

151

0.60

0.78

1.1

2.2

2.70

1.08

ug/l

—

139

Melanocytic naevi of other and unspecified parts of face

1.62

0.78

2.7

2.0

1.44

1.13

ug/l

0.28

Erosion of teeth , including avohilmo

438

1.23

0.77

2.1

2.7

1.32

1.25

ug/l

0.09

410

Papulosquamous disorders

529

1.21

0.77

2.5

1.06

1.00

ug/l

0.06

499

Viral conjunctivitis

1.70

0.75

4.2

3.0

2.08

1.36

ug/l

—

Use of antiglaucoma preparations and miotics

1.70

0.75

1.3

1.8

3.56

1.40

ug/l

—

Oral lichen planus, including avohilmo , including avohilmo

1.64

0.75

1.0

2.1

0.67

1.32

ug/l

1.44

Congenital malformations of gallbladder, bile ducts and liver

2.10

0.75

5.6

5.2

4.07

1.68

ug/l

—

Covid-19 suspected case

369

0.76

0.73

3.1

2.5

0.99

1.20

ug/l

0.40

343

Mental and behavioural disorders due to alcohol

759

1.17

0.73

1.6

2.2

1.09

0.93

ug/l

0.32

698

Glomerular disorders in diseases classified elsewhere

133

1.43

0.73

2.0

2.4

2.39

1.10

ug/l

1.01

122

Other congenital malformations of limb(s)

2.02

0.73

5.4

5.0

1.60

2.60

ug/l

—

Desensitization to allergens

100

1.50

0.72

2.8

3.1

0.68

1.10

ug/l

0.91

Alcohol use disorder, Swedish definition

768

1.16

0.72

1.7

2.2

1.22

0.90

ug/l

0.71

703

Fibrosis and cirrhosis of liver

1.55

0.71

4.8

2.1

2.50

1.22

ug/l

0.61

Prolonged pregnancy

262

0.73

0.71

2.0

2.1

0.65

1.24

ug/l

1.90

248

Familial hypercholesterolemia

117

1.45

0.71

1.0

2.4

1.37

1.05

ug/l

0.25

110

Percutaneous Coronary Intervention

141

764

1.13

0.71

2.5

2.7

1.37

1.09

ug/l

0.72

134

721

Molar incisor enamel hypoplasia, with caries

1.56

0.71

4.9

6.1

1.57

2.25

ug/l

0.87

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

107

1.48

0.71

6.3

6.0

1.92

2.40

ug/l

0.49

107

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.93

0.71

4.0

4.9

1.39

1.77

ug/l

—

Malignant neoplasm of breast, ER-positive, including Hilmo

292

0.77

0.70

1.7

2.2

2.32

1.15

ug/l

1.02

279

Transitory endocrine and metabolic disorders specific to fetus and newborn

107

1.48

0.70

6.3

6.0

1.92

2.40

ug/l

0.49

107

Other retinal disorders

624

1.16

0.70

2.1

2.3

1.56

1.05

ug/l

0.94

591

Coronary revascularization (ANGIO or CABG)

141

764

1.13

0.70

2.5

2.7

1.37

1.09

ug/l

0.72

134

721

Injury of muscle and tendon at hip and thigh level

126

1.43

0.70

1.9

2.8

1.18

1.03

ug/l

0.16

115

All dysplastic lesions of the cervix uteri

451

0.79

0.70

2.4

2.1

1.63

1.30

ug/l

0.36

430

Impacted maxillary canine

1.86

0.68

6.4

5.4

0.58

1.34

ug/l

—

Juvenile arthritis (FINNGEN)

110

1.46

0.68

1.3

4.2

0.55

1.59

ug/l

4.15

104

Malignant neoplasm

168

891

1.12

0.68

2.4

2.5

1.33

1.13

ug/l

0.50

160

837

Sulfasalazine

383

1.23

0.67

2.2

2.6

1.63

1.11

ug/l

0.76

358

Status post-ami

182

0.71

0.67

1.6

2.2

1.81

0.89

ug/l

0.99

170

Motorcycle rider injured in other and unspecified transport accidents

1.49

0.66

1.4

2.8

0.65

1.35

ug/l

1.49

Obstructed labour due to maternal pelvic abnormality

179

0.67

0.66

2.8

2.1

1.03

1.07

ug/l

0.03

173

Transient ischemic attack

443

1.19

0.66

2.5

2.3

1.30

0.93

ug/l

0.66

427

Inguinal hernia, bilateral

111

1.44

0.65

4.4

2.5

1.87

1.10

ug/l

0.66

103

Inguinal or femoral hernia, bilateral

111

1.44

0.65

4.4

2.5

1.87

1.10

ug/l

0.66

103

Inguinal hernia

111

651

1.14

0.65

2.7

2.3

1.43

1.03

ug/l

0.95

106

600

Injury of other and unspecified intrathoracic organs

1.57

0.65

2.3

2.4

0.80

1.13

ug/l

0.43

Inflammatory bowel disease

504

1.19

0.64

2.1

2.6

1.16

1.14

ug/l

0.04

470

Fetus and newborn affected by noxious influences transmitted via placenta or breast milk

0.00

0.62

0.0

6.9

—

2.92

—

Ischaemic Stroke, excluding all haemorrhages

451

1.17

0.62

2.3

1.06

1.01

ug/l

0.09

431

Other congenital malformations, not elsewhere classified

1.68

0.61

5.0

5.8

1.65

1.90

ug/l

—

Malignant neoplasm of breast, HER-positive

288

0.78

0.61

1.7

2.2

2.32

1.15

ug/l

1.02

276

Cardiac arrest

1.59

0.61

1.1

2.6

1.99

1.11

ug/l

—

Otalgia

130

1.39

0.61

2.3

3.8

0.70

1.60

ug/l

2.24

125

Major coronary heart disease event

149

808

1.11

0.60

2.4

2.7

1.34

1.08

ug/l

0.70

141

762

Alcohol use disorder, ICD-based

619

1.16

0.60

1.6

2.2

1.14

0.94

ug/l

0.34

568

Crowding of teeth, including avohilmo

246

1.25

0.60

4.4

4.0

1.63

1.66

ug/l

0.04

238

Tonsillectomy and adenotomy

149

934

1.11

0.59

2.8

1.28

1.30

ug/l

0.05

137

875

103

822

1.13

0.59

1.6

2.2

1.04

0.92

ug/l

0.27

755

Contraceptive management

538

1.15

0.59

1.9

2.0

0.94

0.90

ug/l

0.09

492

Hypertrophy of breast in women and men

263

1.26

0.59

1.6

2.3

0.64

1.17

ug/l

2.17

245

Other and unspecified psoriasis

1.53

0.59

2.1

1.8

0.43

1.20

ug/l

1.84

Benign neoplasm of bone and articular cartilage

114

1.41

0.58

1.5

2.3

0.91

1.44

ug/l

0.75

105

Supervision of normal pregnancy

242

0.80

0.58

1.5

1.9

1.08

1.04

ug/l

0.06

228

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1.52

0.58

1.5

1.9

1.03

1.26

ug/l

0.18

Ischaemic heart disease, wide definition

118

650

1.12

0.58

2.0

2.2

1.19

0.98

ug/l

0.52

113

609

Conjunctivitis (acute, non atopic)

509

1.18

0.57

3.3

3.2

1.37

1.44

ug/l

0.09

480

Alcohol dependence

355

1.21

0.57

1.6

2.3

1.35

1.00

ug/l

0.41

332

Degenerative macular diseases

1.43

0.56

3.0

1.8

1.34

1.17

ug/l

0.07

Other complications of labour and delivery, not elsewhere classified

221

0.75

0.56

3.7

2.1

0.74

1.06

ug/l

0.60

208

Bacterial meningitis

1.54

0.53

4.0

2.1

1.08

0.83

ug/l

—

Cardiovascular disorders originating in the perinatal period

1.52

0.52

6.7

6.0

3.00

2.45

ug/l

—

Use of disulfiram, acamprosate or naltrexone

117

1.37

0.52

2.3

2.5

2.44

1.00

ug/l

0.86

104

Amiodarone users

0.62

0.52

1.0

2.0

1.09

1.25

ug/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

664

1.14

0.51

1.6

2.1

1.09

0.93

ug/l

0.28

607

Alcohol-induced acute pancreatitis

1.47

0.50

1.0

2.8

2.49

0.94

ug/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

1.43

0.49

4.8

2.0

0.85

1.07

ug/l

0.15

Other diseases of pancreas

1.43

0.49

1.2

2.2

0.58

1.40

ug/l

1.94

Benign neoplasm: Skin, unspecified

1.56

0.49

4.6

3.0

1.71

1.40

ug/l

—

Benign neoplasm of urinary organs

1.56

0.49

1.0

1.9

3.05

1.30

ug/l

—

Other pleural conditions

1.40

0.48

3.4

2.0

0.80

1.30

ug/l

0.95

Psoriasis vulgaris

244

1.23

0.48

2.8

2.3

0.53

0.99

ug/l

2.27

228

Use of donepezil

114

1.34

0.47

1.1

1.8

0.63

1.34

ug/l

2.06

106

Other congenital malformations of the digestive system

136

1.32

0.47

5.8

5.0

2.35

2.11

ug/l

0.14

131

Spirochaetal infections, other/unspecified

102

1.37

0.47

1.6

2.2

1.31

1.50

ug/l

0.14

Diabetic neuropathy

142

0.70

0.47

1.1

2.2

2.04

1.01

ug/l

—

130

Congenital deformities of hip

1.46

0.47

2.3

5.0

2.39

2.21

ug/l

—

Glaucoma, exfoliation

1.47

0.47

1.3

1.8

1.02

1.20

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

117

0.68

0.45

3.0

2.3

2.12

1.01

ug/l

—

110

All dysplastic lesions of the cervix uteri, vagina or vulva

486

0.85

0.45

2.2

2.1

1.66

1.29

ug/l

0.48

463

Coronary artery bypass grafting

173

0.77

0.45

1.4

2.2

1.01

0.83

ug/l

0.27

162

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

1.40

0.45

2.7

1.9

0.51

1.54

ug/l

—

Uterine polyps

1.40

0.44

2.8

2.1

1.66

1.16

ug/l

0.39

Pleural plaque with presence of asbestos

1.37

0.44

1.9

1.4

0.60

0.97

ug/l

—

Other congenital malformations of ear

1.62

0.43

1.8

5.7

2.40

2.13

ug/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

722

1.12

0.42

2.0

2.6

1.08

1.15

ug/l

0.12

676

Solid cancers, helper endpoint

158

861

1.08

0.42

2.3

2.4

1.35

1.13

ug/l

0.57

150

809

Glomerulonephritis

162

0.74

0.42

2.7

3.4

1.47

1.37

ug/l

0.06

151

Fetus and newborn affected by maternal complications of pregnancy

1.39

0.42

5.9

6.3

2.76

2.58

ug/l

—

Benign mammary dysplasia

131

1.30

0.42

2.0

2.2

1.06

1.18

ug/l

0.10

124

Congenital malformations of the musculoskeletal system, not elsewhere classified

1.52

0.41

1.2

3.8

0.66

1.82

ug/l

—

Carcinoma in situ of cervix uteri, endocervix

0.00

0.41

0.0

1.7

—

1.22

—

Adalimumab

150

0.73

0.41

1.5

2.7

0.61

1.05

ug/l

0.73

137

Defects in the complement system

0.00

0.41

0.0

5.3

—

2.39

—

Mental and behavioural disorders of puerperium, not classified elsewhere

0.00

0.41

0.0

1.9

—

1.53

—

Gender identity disorders

0.00

0.41

0.0

2.3

—

1.35

—

L02BA Anti-estrogens

161

0.74

0.41

1.5

2.0

0.99

1.08

ug/l

0.12

152

Shigellosis

0.00

0.41

0.0

4.5

—

1.60

—

Poor fetal growth

213

1.22

0.40

2.2

2.1

0.76

1.20

ug/l

1.24

201

Tic and related disorders

1.47

0.40

5.8

5.6

1.87

1.68

ug/l

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

228

1.21

0.40

4.4

4.6

1.66

1.91

ug/l

0.27

220

Viral warts

159

1.26

0.40

3.5

3.0

1.44

1.39

ug/l

0.03

146

Dementia in Alzheimer disease

1.37

0.40

1.2

1.9

1.69

1.28

ug/l

0.22

Emergency coronary revascularization (for ACS)

144

808

1.08

0.40

2.5

2.7

1.38

1.09

ug/l

0.80

137

762

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

103

0.68

0.39

1.1

2.1

0.40

1.20

ug/l

—

Dislocation, sprain and strain of joints and ligaments of head

1.41

0.39

1.9

3.7

2.58

1.65

ug/l

—

Cleft palate

0.00

0.39

0.0

4.8

—

1.84

—

Caries in Clefts patients

0.00

0.39

0.0

4.1

—

1.72

—

Anorexia

0.00

0.39

0.0

3.0

—

1.28

—

Other coagulation defects

106

1.32

0.39

1.6

2.7

1.62

1.04

ug/l

0.25

Impacted cerumen

115

1.31

0.38

3.1

2.8

1.47

1.51

ug/l

0.03

108

Embedded teeth, including avohilmo

169

1.24

0.38

3.3

2.5

1.21

1.14

ug/l

0.06

154

Other congenital malformations of the digestive system

159

1.25

0.38

5.4

5.0

2.42

2.07

ug/l

0.23

154

Acute peritonitis

1.34

0.38

2.7

2.4

3.95

1.18

ug/l

—

L04AD Calcineurin inhibitors

197

1.22

0.37

3.8

3.6

2.64

1.43

ug/l

1.36

182

Diffuse large B-cell lymphoma

1.35

0.37

1.8

1.9

1.38

1.50

ug/l

—

Diffuse large B-cell lymphoma, including Hilmo

1.35

0.37

1.8

1.9

1.38

1.50

ug/l

—

Diffuse large B-cell lymphoma, helper endpoint

1.35

0.37

1.8

1.9

1.38

1.50

ug/l

—

Secondary uncertain malignant neoplasm

125

1.28

0.36

2.5

2.4

1.31

1.17

ug/l

0.11

114

Disorders of continuity of bone

134

1.27

0.36

3.5

2.5

1.54

1.35

ug/l

0.20

122

Lung diseases due to external agents

134

1.27

0.36

1.1

2.2

0.79

1.30

ug/l

0.74

124

Medical abortion

537

0.91

0.36

2.1

2.0

1.12

1.24

ug/l

0.28

518

IBD patients in KELA-register

374

1.15

0.36

2.2

2.5

1.36

1.16

ug/l

0.38

347

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

223

1.20

0.35

2.0

2.4

1.04

0.95

ug/l

0.17

208

Foreign body in respiratory tract

0.62

0.35

1.2

3.3

2.37

1.66

ug/l

—

Polypectomy (DHB20)

0.62

0.35

3.8

2.7

0.74

1.29

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

126

0.71

0.35

3.3

2.2

1.92

1.02

ug/l

—

118

Otosclerosis

1.37

0.34

2.0

2.3

0.80

1.25

ug/l

—

Disorders of choroid and retina

123

810

1.08

0.34

2.2

2.3

1.32

1.02

ug/l

0.67

117

765

Salpingitis and oophoritis

200

1.20

0.33

1.3

2.3

1.17

1.18

ug/l

0.01

189

Malignant neoplasm of bronchus and lung

119

0.77

0.32

1.2

2.2

0.89

0.94

ug/l

0.08

109

Seronegative rheumatoid arthritis

119

1.26

0.31

2.6

2.2

1.49

1.20

ug/l

0.20

112

Myopia

220

1.18

0.31

1.6

2.9

0.81

1.38

ug/l

1.70

201

Dermatophytosis

109

1010

1.08

0.31

2.4

2.3

0.95

1.11

ug/l

0.53

100

939

Pedal cyclist injured in noncollision transport accidents

174

1.21

0.31

2.2

2.8

1.80

1.15

ug/l

0.56

158

Congenital deformities of hip

1.35

0.31

2.3

5.2

2.39

2.18

ug/l

—

L01XE Protein kinase inhibitors

1.32

0.30

1.0

1.9

1.46

1.31

ug/l

—

Malignant neoplasm of pancreas

1.32

0.30

3.6

1.6

0.85

1.41

ug/l

—

Abnormal findings on antenatal screening of mother

147

1.23

0.30

3.4

2.1

0.68

1.19

ug/l

1.71

139

Contact with nonpowered hand tool

1.30

0.30

1.1

2.2

1.84

1.32

ug/l

—

Abnormal findings on examination of urine, without diagnosis

1.27

0.30

3.0

2.4

1.42

1.77

ug/l

—

Ptosis of eyelid

102

1.28

0.30

2.2

1.53

1.21

ug/l

0.21

Malignant neoplasm of bronchus and lung, including Hilmo

145

0.81

0.28

1.4

2.1

1.14

0.86

ug/l

0.41

132

Hypertrophic scar

1.32

0.28

2.5

2.8

0.97

0.96

ug/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

1.28

0.28

2.9

2.2

1.56

1.32

ug/l

0.14

Benign neoplasm: Choroid

1.27

0.27

1.1

1.9

2.15

1.28

ug/l

—

Carcinoma in situ of cervix uteri

149

1.21

0.27

2.2

1.9

1.53

1.16

ug/l

0.23

140

Non-small cell lung cancer, including Hilmo

110

0.77

0.27

1.2

2.2

1.24

0.98

ug/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

117

0.77

0.27

3.3

2.1

1.92

1.14

ug/l

—

112

Chronic pancreatitis

131

1.22

0.27

3.1

2.0

2.45

1.10

ug/l

0.74

121

Pleural plaque

1.23

0.27

1.8

1.3

0.89

0.93

ug/l

—

Infections with a predominantly sexual mode of transmission

689

1.08

0.26

1.9

2.2

1.78

1.07

ug/l

1.70

646

Alcohol-induced chronic pancreatitis

0.67

0.25

2.8

2.7

3.37

1.19

ug/l

—

Other and unspecified disorders of psychological development

1.25

0.25

4.9

6.2

4.65

1.74

ug/l

—

Injury of unspecified body region

114

1.23

0.25

1.1

2.7

1.13

1.50

ug/l

0.31

106

Pneumonitis due to solids and liquids

1.18

0.24

1.1

2.3

0.63

1.41

ug/l

—

Twin gestation

142

1.20

0.24

2.3

2.4

0.51

1.16

ug/l

2.38

135

Cysts of oral region, not elsewhere classified

1.28

0.24

4.0

2.7

1.23

1.24

ug/l

—

Foreign body or object entering through skin

0.72

0.24

1.2

2.6

1.46

1.48

ug/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.71

0.24

1.8

0.85

1.05

ug/l

—

Other disorders of amniotic fluid and membranes

240

1.14

0.23

3.0

2.2

1.43

1.13

ug/l

0.32

227

Glomerular diseases

246

1.14

0.23

2.1

3.1

1.89

1.28

ug/l

0.58

229

Congenital musculoskeletal deformities of head, face, spine and chest

1.28

0.23

4.6

5.3

1.93

1.83

ug/l

—

Superficial injury of wrist and hand

361

1.11

0.22

1.5

2.8

1.26

1.29

ug/l

0.03

340

Other disorders originating in the perinatal period

1.27

0.22

4.8

6.1

1.64

2.07

ug/l

—

Other and unspecified injuries of head

0.77

0.22

3.4

3.0

1.91

1.61

ug/l

—

Dislocation, sprain and strain of joints and ligaments of thorax

1.25

0.22

1.6

2.0

0.52

1.16

ug/l

—

Hypertrophy of breast

221

0.86

0.22

1.1

2.2

0.67

1.17

ug/l

1.62

208

1.22

0.22

4.8

5.3

1.67

1.41

ug/l

—

Underdevelopment of the second kidney

0.00

0.21

0.0

6.3

—

3.54

—

Disorder of visual pathways, unspecified

0.00

0.21

0.0

5.5

—

0.82

—

Congenital malformations of ear causing impairment of hearing

0.00

0.21

0.0

5.3

—

0.98

—

Syndactyly

0.00

0.21

0.0

4.9

—

2.92

—

Mitochondrial myopathy

0.00

0.21

0.0

3.5

—

2.14

—

Congenital cataract

0.00

0.21

0.0

4.0

—

2.76

—

Congenital lens malformations

0.00

0.21

0.0

4.0

—

2.76

—

Cleft hard palate NOS

0.00

0.21

0.0

5.4

—

1.74

—

Pre-eclampsia superimposed on chronic hypertension

0.00

0.21

0.0

2.5

—

1.20

—

Benign neoplasm: Brain, infratentorial

0.00

0.21

0.0

4.4

—

1.19

—

Other congenital malformations of upper alimentary tract

0.00

0.21

0.0

4.2

—

3.05

—

Burns and corrosions of multiple body regions

0.00

0.21

0.0

3.7

—

1.13

—

Peptic ulcer

0.00

0.21

0.0

2.9

—

1.54

—

Migraine with aura, drug-induced

0.00

0.21

0.0

2.3

—

1.63

—

Other disorders of choroid

0.00

0.21

0.0

2.4

—

2.19

—

Aphakia

0.00

0.21

0.0

2.5

—

1.30

—

Motor neuron disease

0.00

0.21

0.0

1.8

—

1.67

—

Other perinatal haematological disorders

0.00

0.21

0.0

6.2

—

2.46

—

Craniosynostosis EXCLUDE syndromes

0.00

0.21

0.0

6.0

—

3.28

—

Pectus excavatum

0.00

0.21

0.0

5.4

—

2.92

—

Dysplastic lesion of unknown severity of the cervix uteri

0.00

0.21

0.0

2.2

—

1.44

—

Tic disorders

1.16

0.21

5.8

5.3

1.87

1.64

ug/l

—

Inflammatory bowel disease, strict (require KELA)

392

1.10

0.21

2.2

2.5

1.36

1.20

ug/l

0.29

365

Atrioventricular septal defect

0.00

0.21

0.0

4.8

—

3.13

—

Other congenital malformations of female genitalia

0.00

0.21

0.0

3.5

—

1.46

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

0.21

0.0

2.1

—

1.36

—

Drug-induced hypoglycaemia without coma

0.00

0.21

0.0

2.7

—

1.05

—

Inflammatory disorders of breast

1.24

0.21

2.5

2.2

0.99

1.17

ug/l

0.14

Aortic hypoplasia

0.00

0.20

0.0

6.3

—

3.46

—

Cystic kidney disease

1.25

0.20

5.0

3.5

2.58

1.83

ug/l

—

Other chronic obstructive pulmonary disease, including avohilmo

484

1.08

0.20

1.6

2.3

1.55

0.95

ug/l

1.06

461

Alzheimer disease, including avohilmo

162

1.13

0.19

1.3

1.7

1.48

1.17

ug/l

0.29

151

Neonatal jaundice from other and unspecified causes

123

1.19

0.19

6.2

6.0

3.71

2.13

ug/l

1.23

123

Cystic kidney disease

1.18

0.19

5.0

3.4

2.58

1.90

ug/l

—

Valvular operations

165

0.85

0.19

4.2

3.4

2.21

1.28

ug/l

0.69

156

Vitamin B12 deficiency anaemia

1.22

0.19

1.7

1.8

0.68

1.22

ug/l

1.07

Separation of retinal layers (serosa)

1.15

0.19

1.0

2.3

1.26

0.97

ug/l

—

Carcinoma in situ of skin of other and unspecified parts of face

1.15

0.19

1.0

1.6

1.49

1.77

ug/l

—

Amputation

1.23

0.18

1.2

1.8

0.91

0.99

ug/l

—

Antepartum haemorrhage, not elsewhere classified

143

0.84

0.18

1.9

2.3

0.76

1.21

ug/l

0.77

136

Superficial injury of shoulder and upper arm

153

0.85

0.18

1.1

2.5

0.59

1.22

ug/l

2.07

136

Alzheimer disease

135

1.14

0.18

1.3

1.7

1.66

1.17

ug/l

0.41

126

Congenital malformations of the urinary system

119

1.18

0.17

4.1

4.0

1.96

1.71

ug/l

0.19

112

Use of memantine

122

1.15

0.17

1.6

1.7

1.16

1.28

ug/l

0.09

113

Use of other anti-dementia drugs

122

1.15

0.17

1.6

1.7

1.16

1.28

ug/l

0.09

113

LSIL lesion of the cervix uteri

184

0.87

0.17

2.9

2.1

1.83

1.18

ug/l

0.42

173

Anterior Iridocyclitis

278

0.90

0.17

3.0

2.4

0.79

1.14

ug/l

0.67

258

Atopic conjunctivitis

0.71

0.16

2.8

3.2

0.77

1.46

ug/l

—

Other congenital malformations of tongue, mouth and pharynx

1.17

0.16

5.3

5.5

1.26

2.37

ug/l

—

Ascites

1.14

0.16

1.6

2.5

1.21

1.18

ug/l

—

Postprocedural musculoskeletal disorders, not elsewhere classified

1.13

0.16

1.0

1.8

0.62

1.26

ug/l

—

Malignant neoplasm of urinary organs

1.20

0.16

1.4

2.2

1.60

1.18

ug/l

0.13

Conotruncal defects

0.79

0.15

4.3

5.9

2.93

1.94

ug/l

—

Contact with other sharp object(s)

111

1.17

0.15

1.8

2.7

1.55

1.34

ug/l

0.15

100

Polyhydramnios

0.78

0.15

1.0

2.1

0.22

1.50

ug/l

—

Multiple gestation

149

1.14

0.15

2.3

0.51

1.16

ug/l

2.41

142

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

0.76

0.15

2.5

2.2

0.62

1.17

ug/l

—

COPD-related respiratory insufficiency

102

1.18

0.15

1.0

1.9

2.47

0.93

ug/l

0.69

ILD, hospital admissions

150

0.87

0.14

1.9

2.4

1.24

1.31

ug/l

0.06

140

Other interstitial pulmonary diseases

150

0.87

0.14

1.9

2.4

1.24

1.31

ug/l

0.06

140

Interstitial lung disease endpoints

150

0.87

0.14

1.9

2.4

1.24

1.31

ug/l

0.06

140

Interstitial lung disease

150

0.87

0.14

1.9

2.4

1.24

1.31

ug/l

0.06

140

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.81

0.14

1.7

0.90

1.04

ug/l

—

Hydronephrosis

131

1.15

0.14

1.9

2.3

1.20

1.09

ug/l

0.08

122

Other local infections of skin and subcutaneous tissue

141

1.14

0.13

1.7

2.9

1.52

1.21

ug/l

0.20

130

Puerperal sepsis

141

1.14

0.13

1.6

2.1

0.90

1.10

ug/l

0.40

134

Congenital malformations of the urinary system

122

1.15

0.13

4.1

4.0

1.96

1.70

ug/l

0.20

114

Hydrocele

103

1.17

0.13

2.0

2.9

1.88

0.99

ug/l

0.71

HSIL lesion of the cervix uteri

294

0.92

0.13

2.5

2.1

1.82

1.16

ug/l

0.67

281

Convergent concomitant strabismus

107

0.84

0.13

4.2

3.9

1.25

1.54

ug/l

—

100

Acute lymphadenitis

104

1.15

0.12

2.2

3.3

0.90

1.27

ug/l

0.48

Hypertrophic disorders of skin

1.18

0.12

2.5

2.7

0.97

0.94

ug/l

—

Other diseases of arteries and capillaries

1.16

0.11

2.0

1.04

1.10

ug/l

—

ILD, hospital admissions 1, main diag only

136

0.88

0.11

2.0

1.15

1.31

ug/l

0.13

127

Parkinson's disease, including avohilmo

125

0.88

0.10

3.0

1.8

1.50

1.07

ug/l

0.37

117

Right ventricular outflow tract obstruction

1.09

0.09

4.4

6.3

3.44

2.08

ug/l

—

Overexertion and strenuous or repetitive movements

135

1.11

0.09

1.5

2.4

0.58

1.16

ug/l

1.37

122

Car occupant injured in noncollision transport accident

1.09

0.09

1.4

2.4

0.60

1.17

ug/l

—

Preparatory care for dialysis

1.09

0.09

2.0

2.2

0.84

1.30

ug/l

—

Fall on and from ladder

1.15

0.09

2.2

0.73

1.11

ug/l

—

Intracerebral haemorrhage

1.13

0.09

2.3

2.1

2.38

1.22

ug/l

0.48

Other obstructed labour

107

1.12

0.08

2.1

2.2

0.85

0.99

ug/l

0.15

Unspecified misadventure during surgical and medical care

1.03

0.08

7.0

2.3

0.59

1.25

ug/l

—

Amputation of toe

1.03

0.08

1.3

1.7

0.50

1.10

ug/l

—

Bicuspidal aortic valve syndrome

0.78

0.08

4.6

4.0

1.75

1.42

ug/l

—

Emphysema

0.78

0.08

1.0

2.1

3.64

1.09

ug/l

—

Foreign body entering into or through eye or natural orifice

123

0.89

0.08

1.6

3.2

1.92

1.52

ug/l

0.26

111

Labour and delivery complicated by umbilical cord complications

0.84

0.07

1.2

2.1

1.14

0.90

ug/l

—

Malignant neoplasm of respiratory system and intrathoracic organs

138

1.09

0.07

1.7

2.1

0.99

0.87

ug/l

0.18

125

Malignant neoplasm of head and neck

0.82

0.07

1.7

2.5

0.88

1.03

ug/l

—

Osteomyelitis

1.04

0.07

1.9

2.8

1.21

1.64

ug/l

—

Presbyopia

0.83

0.07

2.3

2.4

0.71

0.90

ug/l

—

Caught, crushed, jammed or pinched in or between objects

1.03

0.07

1.8

3.3

2.24

1.37

ug/l

—

Duodenal ulcer

1.12

0.06

1.6

2.1

3.50

0.90

ug/l

—

Bronchitis, not specified as acute or chronic

1.11

0.06

1.0

2.2

1.35

1.09

ug/l

0.14

Malignant neoplasm of rectum, including Hilmo

104

0.86

0.06

4.3

1.9

0.93

0.99

ug/l

—

LSIL lesion of the cervix uteri, vagina or vulva

213

0.94

0.06

2.5

2.1

1.73

1.16

ug/l

0.44

201

Acute and subacute iridocyclitis

253

0.95

0.05

3.1

2.4

0.82

1.15

ug/l

0.60

235

Left ventricular outflow tract obstruction, narrow definition

110

0.91

0.05

4.7

4.3

4.66

1.72

ug/l

—

103

Speech therapy

323

0.96

0.05

2.6

2.5

1.06

1.14

ug/l

0.16

303

Other respiratory diseases principally affecting the interstitium

170

0.94

0.04

1.9

2.3

1.67

1.27

ug/l

0.31

160

Parkinson's disease

119

0.92

0.04

3.0

1.8

1.50

1.10

ug/l

0.34

111

Glucosamine medication

373

1.03

0.03

1.6

2.2

1.11

1.05

ug/l

0.09

356

Haemangioma and lymphangioma, any site

139

0.94

0.03

1.9

3.1

1.92

1.40

ug/l

0.20

131

Crushed, pushed or stepped on by crowd or human stampede

141

1.06

0.03

1.7

3.3

1.67

1.48

ug/l

0.12

130

Impetigo

108

0.93

0.03

4.1

4.5

1.23

1.58

ug/l

—

103

Unspecified lump in breast

162

1.05

0.02

1.8

2.1

1.41

1.16

ug/l

0.19

152

Overjet

102

1.07

0.02

4.1

5.6

1.84

1.88

ug/l

0.01

102

Non-follicular lymphoma

1.08

0.02

2.3

1.9

1.30

1.32

ug/l

—

Pregnancy with abortive outcome

103

543

0.99

0.02

2.1

2.0

1.18

1.25

ug/l

0.13

524

Other and unspecified local infections of skin and subcutaneous tissue

133

1.05

0.01

1.8

2.9

1.82

1.18

ug/l

—

123

HSIL lesion of the cervix uteri, vagina or vulva

317

0.98

0.01

2.3

2.1

1.78

1.22

ug/l

0.61

302

Impacted maxillary molar

104

1.06

0.01

2.6

2.3

1.43

1.13

ug/l

0.15

Parkinson's disease, strict definition

106

0.94

0.01

2.0

1.8

1.48

1.16

ug/l

—

Seborrhoeic keratosis

216

0.97

0.00

2.0

2.1

1.98

0.86

ug/l

1.08

205

Alzheimer’s disease, strict definition

122

1.01

0.00

1.2

1.7

1.75

1.23

ug/l

0.32

113

Wet age-related macular degeneration

101

0.96

0.00

1.3

1.6

1.18

1.25

ug/l

—

Alzheimer’s disease (Late onset)

106

1.03

0.00

1.2

1.7

2.00

1.34

ug/l

0.38

Myocardial infarction, without ST-elevation

330

0.99

0.00

2.6

2.0

1.19

0.97

ug/l

0.30

311

Allergic urticaria

138

1.01

0.00

2.8

3.3

1.17

1.47

ug/l

0.29

129

Peripheral artery operations in Hilmo

102

0.98

0.00

1.2

1.9

1.31

1.03

ug/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

105

0.95

0.00

2.1

2.4

2.20

1.12

ug/l

—

Haemangioma, any site

122

0.98

0.00

2.0

2.9

0.92

1.49

ug/l

0.86

115

Angina pectoris

451

1.00

0.00

1.5

2.2

1.29

0.94

ug/l

0.63

426

Haemorrhagic and haematological disorders of fetus and newborn

145

0.99

0.00

6.2

5.8

3.71

2.03

ug/l

1.34

145

Chalazion

131

0.99

0.00

2.5

2.6

1.23

1.19

ug/l

0.03

120

Bacterial, viral and other infectious agents

151

0.99

0.00

3.2

3.1

1.19

1.39

ug/l

0.13

138

Follicular cysts of skin and subcutaneous tissue

241

1.00

0.00

2.0

2.2

0.84

1.18

ug/l

0.47

223

Bacterial, viral and other infectious agents

143

0.98

0.00

3.4

3.0

1.26

1.38

ug/l

0.07

130

Non-allergic asthma

134

0.97

0.00

3.5

3.7

2.79

1.49

ug/l

0.58

127

Exposure to excessive heat of man-made origin

0.00

0.0

3.4

—

1.28

—

Tick-borne viral encephalitis

0.00

0.0

2.2

—

2.20

—

Occupant of pick-up truck or van injured in other and unspecified transport accidents

0.00

0.0

2.6

—

0.92

—

Meningococcal infection

0.00

0.0

2.2

—

1.89

—

Enteropathogenic Escherichia coli infection

0.00

0.0

2.8

—

2.21

—

Crushing injury of ankle and foot

0.00

0.0

2.0

—

1.42

—

Neuroendocrine tumor and carcinoma of stomach

0.00

0.0

2.2

—

1.15

—

Idiopathic peripheral autonomic neuropathy

0.00

0.0

3.7

—

4.59

—

Otorrhagia

0.00

0.0

3.8

—

0.90

—

Tic and related disorders

0.98

0.00

5.8

5.3

1.87

1.93

ug/l

—

Other and unspecified heterotropia

0.00

0.0

4.2

—

3.67

—

Toxic effect of organic solvents

0.00

0.0

1.4

—

0.45

—

Congenital absence, occlusion, or narrowing of the ear canal

0.00

0.0

5.3

—

0.87

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

0.0

1.8

—

1.52

—

Labyrinthitis

0.00

0.0

3.3

—

3.96

—

Osteogenesis imperfecta

0.00

0.0

6.7

—

1.68

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

0.00

-0.00

0.0

2.2

—

1.12

—

Traction detachment of retina

0.00

-0.00

0.0

1.8

—

0.79

—

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

0.00

-0.00

0.0

1.9

—

1.59

—

Blindness or visual impairment, binocular

0.00

-0.00

0.0

3.8

—

1.10

—

Gilbert syndrome

0.00

-0.00

0.0

2.6

—

1.20

—

Congenital retinoschisis

0.00

-0.00

0.0

4.2

—

0.75

—

Other inherited muscular atrophy

0.00

-0.00

0.0

5.1

—

1.74

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

-0.00

0.0

1.8

—

1.49

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

0.00

-0.00

0.0

3.3

—

3.96

—

Malignant neoplasm of bladder, including Hilmo

1.01

-0.00

2.0

2.2

1.49

1.06

ug/l

—

Qualitative platelet defects

0.00

-0.00

0.0

5.0

—

1.23

—

Disorders of male genital organs in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

0.25

—

ILD, hospital admission 2, with pulmonary infections

0.97

-0.00

1.8

2.5

1.08

1.24

ug/l

—

ILD, hospital admissions 3, with pneumonia sepsis

0.92

-0.00

1.0

2.0

0.83

1.32

ug/l

—

Malignant neoplasm of kidney, except renal pelvis

0.92

-0.00

1.5

2.2

2.01

1.23

ug/l

—

Congenital malformation of vitreous humour

0.00

-0.00

0.0

3.6

—

4.73

—

Melanocytic naevi of lip

0.00

-0.00

0.0

2.3

—

1.42

—

Eccrine sweat disorders

0.00

-0.00

0.0

3.6

—

2.05

—

Profound mental retardation

0.00

-0.00

0.0

6.4

—

2.71

—

Arthropathy in hypersensitivity reactions classified elsewhere

0.00

-0.00

0.0

3.4

—

3.77

—

Enteritis due to Yersinia enterocolitica

0.00

-0.00

0.0

2.6

—

1.43

—

Idiopathic pulmonary fibrosis

0.86

-0.00

2.0

1.7

1.77

1.41

ug/l

—

Pityriasis lichenoides chronica

0.00

-0.00

0.0

3.6

—

1.40

—

Accessory breast

0.00

-0.00

0.0

2.8

—

2.52

—

Benign neoplasm: Endocrine pancreas

0.00

-0.00

0.0

2.2

—

1.15

—

Digeorge syndrome

0.00

-0.00

0.0

6.2

—

4.81

—

Anoxic brain damage

0.00

-0.00

0.0

3.8

—

1.49

—

Alcoholic cardiomyopathy

0.00

-0.00

0.0

1.4

—

0.28

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

2.7

—

1.70

—

Congenital retinoschisis

0.00

-0.00

0.0

4.2

—

0.75

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

3.0

—

1.99

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

3.5

—

2.54

—

Systemic disorders of connective tissue in diseases classified elsewhere (FG)

0.00

-0.00

0.0

2.7

—

2.80

—

0.00

-0.00

0.0

2.2

—

1.15

—

Cyst of iris, ciliary body and anterior chamber

0.00

-0.00

0.0

3.0

—

5.25

—

Sequelae of burns, corrosions and frostbite

0.00

-0.00

0.0

4.1

—

1.04

—

Acute myringitis

0.00

-0.00

0.0

3.9

—

2.41

—

0.00

-0.00

0.0

2.0

—

1.75

—

Right side

0.00

-0.00

0.0

2.2

—

0.66

—

Personal history of allergy to analgesic agent

0.00

-0.00

0.0

2.0

—

1.52

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

6.0

—

0.86

—

Ankle and foot

0.00

-0.00

0.0

2.2

—

1.47

—

Asymptomatic human immunodeficiency virus [HIV] infection status

0.00

-0.00

0.0

1.0

—

0.80

—

Disorders of porphyrin and bilirubin metabolism

0.00

-0.00

0.0

2.7

—

1.05

—

Pedestrian injured in transport accident

0.92

-0.00

1.4

2.4

2.38

1.14

ug/l

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

-0.00

0.0

2.5

—

1.19

—

Contact with other specified venomous animals

0.00

-0.00

0.0

2.8

—

1.59

—

Lung transplantation

0.00

-0.00

0.0

3.1

—

1.63

—

Open wounds involving multiple body regions

0.00

-0.00

0.0

2.8

—

1.12

—

Foreign body in alimentary tract

0.90

-0.00

3.0

3.1

0.91

1.72

ug/l

—

Effects of heat and light

0.00

-0.00

0.0

2.3

—

1.85

—

Respiratory tuberculosis, clinically confirmed

0.00

-0.00

0.0

3.1

—

1.23

—

Single ventricle heart

0.00

-0.00

0.0

6.1

—

3.48

—

Unicornuate uterus

0.00

-0.00

0.0

2.8

—

1.96

—

Other congenital malformations of respiratory system

0.00

-0.00

0.0

4.6

—

4.17

—

Syndactyly

0.00

-0.00

0.0

5.5

—

0.89

—

Other congenital malformations of eye

0.00

-0.00

0.0

4.6

—

3.01

—

Pectus carinatum

0.00

-0.00

0.0

5.2

—

1.76

—

Fusion of the labia

0.00

-0.00

0.0

5.8

—

1.57

—

Medullary cystic kidney disease, nephronophthisis

0.00

-0.00

0.0

4.4

—

4.68

—

Other trisomies and partial trisomies of the autosomes, not elsewhere classified

0.00

-0.00

0.0

7.7

—

1.30

—

Congenital glaucoma

0.00

-0.00

0.0

4.0

—

2.71

—

Congenital malformations of aortic and mitral valves

0.98

-0.00

5.1

4.3

3.29

1.64

ug/l

—

Congenital malformations of nose

0.00

-0.00

0.0

3.4

—

1.39

—

Cleft lip and palate

0.00

-0.00

0.0

5.8

—

1.28

—

Haemolytic disease of fetus and newborn

0.00

-0.00

0.0

5.2

—

2.98

—

Neonatal aspiration syndromes

0.00

-0.00

0.0

5.0

—

1.11

—

Infections specific to the perinatal period

0.94

-0.00

7.4

5.9

2.01

2.05

ug/l

—

Artificial joint re-operation

0.98

-0.00

2.2

1.9

0.78

1.59

ug/l

—

Unspecified renal colic

0.00

-0.00

0.0

1.8

—

1.80

—

Use of peginterferon beta-1a

0.00

-0.00

0.0

3.2

—

1.72

—

Dermatopolymyositis, unspecified

0.00

-0.00

0.0

2.2

—

1.91

—

Ventricular septal defect, a heart condition

0.91

-0.00

3.8

6.1

3.77

2.27

ug/l

—

Migraine, unspecified, drug-induced

0.00

-0.00

0.0

2.5

—

1.61

—

Hypertrophy of bone

0.00

-0.00

0.0

2.6

—

0.50

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

-0.00

0.0

3.8

—

1.45

—

Generalized pustular psoriasis

0.00

-0.00

0.0

3.2

—

1.66

—

Other and unspecified hypertrophic disorders of skin

0.00

-0.00

0.0

2.4

—

0.99

—

Ankylosis of joint

0.00

-0.00

0.0

1.6

—

0.86

—

Other and unspecified papulosquamous disorders

0.00

-0.00

0.0

2.0

—

1.61

—

Hair colour and hair shaft abnormalities

0.00

-0.00

0.0

2.1

—

1.61

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

-0.00

0.0

2.7

—

4.49

—

Carcinoma in situ of breast, intraductal

0.99

-0.00

4.3

1.9

2.29

1.26

ug/l

—

Café au lait spots

0.00

-0.00

0.0

5.1

—

4.76

—

Acute gastritis

0.90

-0.00

3.4

2.1

1.14

1.08

ug/l

—

Scissor bite

0.96

-0.00

6.6

5.3

2.77

1.30

ug/l

—

Pneumonia due to Streptococcus pneumoniae

1.00

-0.00

2.0

2.5

2.35

1.38

ug/l

—

ILD medications: acetylcysteine

0.00

-0.00

0.0

3.4

—

2.34

—

Chylothorax

0.00

-0.00

0.0

5.1

—

2.00

—

Polyp of middle ear

0.00

-0.00

0.0

5.9

—

1.26

—

Glaucoma secondary to drugs

0.00

-0.00

0.0

3.5

—

1.96

—

Stenosis and insufficiency of lacrimal passages

0.94

-0.00

2.3

2.5

0.79

1.21

ug/l

—

Hypertension, portal

0.00

-0.00

0.0

1.0

—

0.98

—

Dissection of cerebral arteries, nonruptured

0.00

-0.00

0.0

2.3

—

0.91

—

Other and unspecified neuropathies

0.00

-0.00

0.0

2.4

—

1.27

—

Food allergy

0.00

-0.00

0.0

4.0

—

2.94

—

Entropion and trichiasis of eyelid

0.97

-0.00

1.0

2.1

1.50

1.40

ug/l

—

Erectile dysfunction, exclusion

0.00

-0.00

0.0

3.8

—

4.07

—

Other specified and unspecified disorders of choroid

0.00

-0.00

0.0

2.0

—

2.53

—

0.00

-0.00

0.0

1.9

—

1.42

—

Carcinoma in situ of uteri, other/unspecified

0.00

-0.00

0.0

2.0

—

1.72

—

Benign lipomatous neoplasm of other sites/unspecified

0.90

-0.00

3.6

1.9

6.19

1.27

ug/l

—

Other benign neoplasm of uterus: Cervix uteri

0.00

-0.00

0.0

2.3

—

2.22

—

Malignant neoplasm of parotid gland

0.00

-0.00

0.0

3.0

—

1.09

—

Folate deficiency anaemia

0.00

-0.00

0.0

1.3

—

1.55

—

Pedal cyclist injured in collision with pedestrian or animal

0.00

-0.00

0.0

2.0

—

1.42

—

Osteosarcoma, including Hilmo

0.00

-0.00

0.0

4.2

—

1.53

—

Ependymoma

0.00

-0.00

0.0

6.0

—

1.76

—

Malignant neoplasm of base of tongue

0.00

-0.00

0.0

2.6

—

1.31

—

Malignant neoplasm of bone and articular cartilage of limbs

0.00

-0.00

0.0

3.2

—

1.51

—

Bacterial sepsis of newborn

1.00

-0.00

7.8

6.2

1.42

2.12

ug/l

—

Maze procedure for atrial fibrillation

0.00

-0.00

0.0

2.2

—

1.12

—

Sequelae of transport accidents

0.00

-0.00

0.0

1.5

—

0.23

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

2.3

—

0.86

—

Other specified/unspecified nutritional deficiencies

0.00

-0.00

0.0

2.5

—

1.86

—

Traumatic amputation of wrist and hand

1.00

-0.00

1.0

2.6

0.59

1.30

ug/l

—

Tick-borne viral encephalitis

0.00

-0.00

0.0

2.2

—

2.20

—

Erysipeloid

0.00

-0.00

0.0

1.3

—

1.79

—

Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases

0.00

-0.00

0.0

2.3

—

0.36

—

Pediculosis and phthiriasis

0.00

-0.00

0.0

2.2

—

1.12

—

Lung transplant status

0.00

-0.00

0.0

3.1

—

1.63

—

Other and unspecified syphilis

0.00

-0.00

0.0

2.2

—

0.35

—

Acute hepatitis B

0.00

-0.00

0.0

2.5

—

0.85

—

Disorders of magnesium metabolism

0.00

-0.00

0.0

2.6

—

0.28

—

Malignant neoplasm of hypopharynx, including Hilmo

0.00

-0.00

0.0

3.8

—

1.45

—

Shigellosis

0.00

-0.00

0.0

2.0

—

1.63

—

Other and unspecified syphilis

0.00

-0.00

0.0

2.2

—

0.35

—

Microtia (small ears)

0.00

-0.00

0.0

6.8

—

0.79

—

Abnormality of red blood cells

0.00

-0.00

0.0

2.2

—

0.36

—

Other and unspecified medical devices associated with adverse incidents

0.00

-0.00

0.0

3.6

—

1.31

—

Exposure to other and unspecified forces of nature

0.00

-0.00

0.0

4.4

—

0.85

—

Rare circulating lymphoid malignancy

0.00

-0.00

0.0

3.6

—

4.10

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Somatotropin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS